<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease - Hussein, N - 2021 | Cochrane Library</title> <meta content="Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease - Hussein, N - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010849.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease - Hussein, N - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010849.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010849.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease" name="citation_title"/> <meta content="Norita Hussein" name="citation_author"/> <meta content="Faculty of Medicine, University of Malaya" name="citation_author_institution"/> <meta content="Lidewij Henneman" name="citation_author"/> <meta content="Amsterdam University Medical Centers" name="citation_author_institution"/> <meta content="Joe Kai" name="citation_author"/> <meta content="Nadeem Qureshi" name="citation_author"/> <meta content="nadeem.qureshi@nottingham.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010849.pub4" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/10/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010849.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010849.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010849.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Anemia, Sickle Cell [genetics]; *Cystic Fibrosis [genetics]; Risk Assessment; *Tay-Sachs Disease [genetics]; *Thalassemia" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010849.pub4&amp;doi=10.1002/14651858.CD010849.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="VXKc2U6b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010849\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010849\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ms","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010849.pub4",title:"Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay\\u2010Sachs disease",firstPublishedDate:"Oct 11, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=VXKc2U6b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010849.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010849.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010849.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010849.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010849.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010849.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010849.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010849.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010849.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010849.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3004 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010849.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-sec-0067"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-sec-0018"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-sec-0049"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-sec-0061"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/appendices#CD010849-sec-0071"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information#CD010849-cr-0004">Norita Hussein</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information#CD010849-cr-0005">Lidewij Henneman</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information#CD010849-cr-0006">Joe Kai</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information#CD010849-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Nadeem Qureshi</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information/en#CD010849-sec-0077">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 October 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010849.pub4">https://doi.org/10.1002/14651858.CD010849.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010849-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010849-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010849-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010849-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010849-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010849-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010849-abs-0001" lang="en"> <section id="CD010849-sec-0001"> <h3 class="title" id="CD010849-sec-0001">Background</h3> <p>Globally, about 6% of children are born with a serious birth defect of genetic or partially genetic origin. Carrier screening or testing is one way to identify couples at increased risk of having a child with an autosomal recessive condition. The most common autosomal recessive conditions are thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease, with higher carrier rates in high‐risk populations of specific ancestral backgrounds. Identifying and counselling couples at genetic risk of the conditions before pregnancy enables them to make fully informed reproductive decisions, with some of these choices not being available if testing is only offered in an antenatal setting. This is an update of a previously published review. </p> </section> <section id="CD010849-sec-0002"> <h3 class="title" id="CD010849-sec-0002">Objectives</h3> <p>To assess the effectiveness of systematic preconception genetic risk assessment to enable autonomous reproductive choice and to improve reproductive outcomes  in women and their partners who are both identified as carriers of thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease in healthcare settings when compared to usual care. </p> </section> <section id="CD010849-sec-0003"> <h3 class="title" id="CD010849-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Trials Registers. Date of latest search of the registers: 04 August 2021. </p> <p>In addition, we searched for all relevant trials from 1970 (or the date at which the database was first available if after 1970) to date using electronic databases (MEDLINE, Embase, CINAHL, PsycINFO), clinical trial databases (National Institutes of Health, Clinical Trials Search portal of the World Health Organization, metaRegister of controlled clinical trials), and hand searching of key journals and conference abstract books from 1998 to date (<i>European Journal of Human Genetics, Genetics in Medicine, Journal of Community Genetics</i>). We also searched the reference lists of relevant articles, reviews and guidelines and also contacted subject experts in the field to request any unpublished or other published trials. Date of latest search of all these sources: 25 June 2021.  </p> </section> <section id="CD010849-sec-0004"> <h3 class="title" id="CD010849-sec-0004">Selection criteria</h3> <p>Any randomised controlled trials (RCTs) or quasi‐RCTs (published or unpublished) comparing reproductive outcomes of systematic preconception genetic risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease when compared to usual care. </p> </section> <section id="CD010849-sec-0005"> <h3 class="title" id="CD010849-sec-0005">Data collection and analysis</h3> <p>We identified 37 papers, describing 22 unique trials which were potentially eligible for inclusion in the review. However, after assessment, we found no RCTs of preconception genetic risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease. </p> </section> <section id="CD010849-sec-0006"> <h3 class="title" id="CD010849-sec-0006">Main results</h3> <p>No RCTs of preconception genetic risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease are included. A trial identified earlier has published its results and has subsequently been listed as excluded in this review. </p> </section> <section id="CD010849-sec-0007"> <h3 class="title" id="CD010849-sec-0007">Authors' conclusions</h3> <p>As there are no RCTs of preconception genetic risk assessment for thalassaemia, sickle cell disease, cystic fibrosis, or Tay‐Sachs disease included in either the earlier or current versions of this review, we recommend considering potential non‐RCTs studies (for example prospective cohorts or before‐and‐after studies) for future reviews. While RCTs are desirable to inform evidence‐based practice and robust recommendations, the ethical, legal and social implications associated with using this trial design to evaluate the implementation of preconception genetic risk assessment involving carrier testing and reproductive autonomy must also be considered.  In addition, rather than focusing on single gene‐by‐gene carrier testing for specific autosomal‐recessive conditions as the intervention being evaluated, preconception expanded genetic screening should also be included in future searches as this has received much attention in recent years as a more pragmatic strategy. </p> <p>The research evidence for current international policy recommendations is limited to non‐randomised studies. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010849-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010849-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010849-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010849-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010849-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010849-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010849-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010849-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010849-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010849-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010849-abs-0002" lang="en"> <h3>Identifying carrier status for thalassaemia, sickle cell disease, cystic fibrosis, or Tay‐Sachs disease in non‐pregnant women and their partners </h3> <p><b>Review question</b> </p> <p>We looked for evidence to show whether identifying people who are carriers for thalassaemia, sickle cell disease, cystic fibrosis, or Tay‐Sachs disease, before pregnancy leads to improving reproductive choice and pregnancy outcomes. </p> <p><b>Background</b> </p> <p>Across the world, about 6% of children are born with a birth defect of genetic or partially genetic origin.  Many of these conditions can be passed down from parent to child. There are tests to identify the genetic risk of the most common genetic conditions (thalassaemia, sickle cell disease, cystic fibrosis, or Tay‐Sachs disease) before pregnancy. In these conditions, called autosomal recessive conditions, the parents of affected children are 'carriers' of the condition, which means they do not usually have symptoms. All 'carrier' couples will have a 25% chance of having an affected child. Risk assessment for these genetic conditions before getting pregnant would benefit potential parents who may be carriers. This information would give the at‐risk couple the opportunity to make fully informed decisions about family planning. However, genetic risk assessment before pregnancy may potentially have a negative psychological impact. This is an updated version of the original review. </p> <p><b>Search date</b> </p> <p>We last looked for evidence on 04 August 2021.</p> <p><b>Study characteristics</b> </p> <p>We did not find any trials that we could include in this review. In an earlier version of this review, we had already found the protocol for a trial that has now published its results, but we have excluded the trial in this version of the review because it did not look at the right topic after all. </p> <p><b>Key results</b> </p> <p>Although no trials were identified in which people taking part would have equal chances of being in either group, there are several studies which are not so strictly designed which support current policy recommendations for genetic risk assessment prior to pregnancy in routine clinical practice. We recommend considering potential observational studies in future reviews as well as looking at ‘expanded carrier screening’ before pregnancy and not just screening for one condition. Any future trials need to consider legal, ethical and cultural barriers to implementing genetic risk assessment before pregnancy. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010849-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010849-sec-0067"></div> <h3 class="title" id="CD010849-sec-0068">Implications for practice</h3> <section id="CD010849-sec-0068"> <p>We have not identified any relevant trials up to the 2021 update and this systematic review shows that there is a complete lack of randomised controlled trials (RCTs) in the field of preconception genetic risk assessment for autosomal recessive conditions.  </p> <p>As such, healthcare providers need to assess whether the information provided in published policy recommendations (see below) and non‐randomised studies (for example prospective cohorts or before‐and‐after studies) is relevant to inform their preconception screening practice. While RCTs are theoretically desirable to inform evidence‐based practice and robust recommendation, such trials must also consider the ethical, legal and social implications associated with implementation of preconception genetic risk assessment involving carrier testing and reproductive autonomy. Perhaps it is time to rethink whether using RCTs to explore the evidence for reproductive genetic risk assessment is the way to move forward when recommending policy? Furthermore, to consider whether it is ethically acceptable to involve women and men preconceptionally for genetic carrier testing in prospective randomised trials? Healthcare providers have to balance the benefits of increasing reproductive choice against the potential psychological adverse effects from preconception genetic risk assessment, whilst taking into account the legal and socia‐cultural context of their healthcare setting and patient population.  </p> <p>Despite the lack of RCT evidence and the research evidence for current policy recommendations being limited to non‐randomised studies, a number of international organisations have recommended offering preconception genetic risk assessment routinely at the population level (<a href="./references#CD010849-bbs2-0023" title="American College of Obstetricians and Gynecologists. Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. ACOG Committee Opinion No. 442 Obstetrics &amp; Gynecology2009;114:950-3.">ACOG Committee Opinion 2009</a>; <a href="./references#CD010849-bbs2-0024" title="American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. ACOG Committee Opinion No. 6912017;129(3):41-55.">ACOG Committee Opinion 2017</a>; <a href="./references#CD010849-bbs2-0025" title="American College of Obstetricians and Gynecologists. Carrier screening in the age of genomic medicine. ACOG Committee Opinion No. 6902017;129(3):595-6.">ACOG Committee Opinion 2017 (reaffirmed 2020)</a>; <a href="./references#CD010849-bbs2-0064" title="Health Council of Netherlands. Preconception care: A good beginning. The Hague: Health Council of Netherlands2007. [ISBN: 978-90-5549-678-5]">Health Council of Netherlands 2007</a>; <a href="./references#CD010849-bbs2-0069" title="Human Genetics Commission. Increasing options, informing choice: A report on preconception genetic testing and screening. Human Genetics Commission2011.">Human Genetics Commission 2011</a>; <a href="./references#CD010849-bbs2-0071" title="JohnsonK , PosnerSF , BiermannJ , CorderoJF , AtrashHK , ParkerCS , et al. Recommendations to improve preconception health and health care--United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recommendation Report2006;55(RR-6):1-23.">Johnson 2006</a>; <a href="./references#CD010849-bbs2-0083" title="ChristiansonA , HowsonCP , ModellB . Global Report on Birth Defects. The hidden toll of dying and disabled children. Available from www.marchofdimes.org/materials/global-report-on-birth-defects-the-hidden-toll-of-dying-and-disabled-children-executive-summary.pdf 2006 (accessed 28 July 2021).">March of Dimes 2006</a>). In the USA, the recommendations to improve preconception healthcare were developed through collaborative efforts of the Centres for Disease Control and Prevention (CDC), March of Dimes and the American College of Obstetrics and Gynaecology (ACOG) (<a href="./references#CD010849-bbs2-0024" title="American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. ACOG Committee Opinion No. 6912017;129(3):41-55.">ACOG Committee Opinion 2017</a>; <a href="./references#CD010849-bbs2-0071" title="JohnsonK , PosnerSF , BiermannJ , CorderoJF , AtrashHK , ParkerCS , et al. Recommendations to improve preconception health and health care--United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recommendation Report2006;55(RR-6):1-23.">Johnson 2006</a>). For instance, the ACOG Committee has recommended that for couples planning pregnancy to identify if either member of the couple are of Eastern European (Ashkenazi) Jewish ancestry or have a family history of relevant recessive genetic diseases (such as Tay‐Sachs disease and Cystic Fibrosis), and furthermore that such couples should be offered carrier screening before conception or early in pregnancy (<a href="./references#CD010849-bbs2-0023" title="American College of Obstetricians and Gynecologists. Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. ACOG Committee Opinion No. 442 Obstetrics &amp; Gynecology2009;114:950-3.">ACOG Committee Opinion 2009</a>; <a href="./references#CD010849-bbs2-0024" title="American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. ACOG Committee Opinion No. 6912017;129(3):41-55.">ACOG Committee Opinion 2017</a>). </p> <p>Similarly, the Health Council of Netherlands has recognised the seriousness of these conditions and high prevalence in local population groups, advocating preconception genetic risk assessment for cystic fibrosis, sickle cell and thalassaemia (<a href="./references#CD010849-bbs2-0064" title="Health Council of Netherlands. Preconception care: A good beginning. The Hague: Health Council of Netherlands2007. [ISBN: 978-90-5549-678-5]">Health Council of Netherlands 2007</a>). However, despite local initiatives, large‐scale studies have not been implemented in the Netherlands (<a href="./references#CD010849-bbs2-0052" title="Delatycki, MB, Alkuraya, F, Archibald, A, et al. International perspectives on the implementation of reproductive carrier screening.. Prenatal Diagnosis2020;20:301-10. [DOI: 10.1002/pd.5611]">Delatycki 2019</a>). </p> <p>The WHO's Regional Office of Eastern Mediterranean recommends preconception genetic risk assessment for sickle cell and thalassaemia ideally before marriage, taking account of the socio‐cultural issues in the region, in particular religious reservations towards the termination of pregnancy (<a href="./references#CD010849-bbs2-0027" title="AlwanA , ModellB . EMRO Technical Publication 24. Alexandria: Eastern Mediterranean Regional Office: World Health Organization, 1997.">Alwan 1997</a>). Since the 1970s, the Cyprus Thalassaemia Control Programme has been at the forefront of premarital genetic screening and this has contributed to a fall in the prevalence of thalassaemia in the country (<a href="./references#CD010849-bbs2-0028" title="AngastiniotisMA , HadjiminasMG . Prevention of thalassaemia in Cyprus. Lancet1981;1(8216):369-71.">Angastiniotis 1981</a>). This universal premarital approach to thalassaemia carrier screening has also been adopted by Sardinia, Italy (<a href="./references#CD010849-bbs2-0044" title="CaoA , RosatelliMC , GallanelloR . Control of beta-thalassaemia by carrier screening, genetic counselling, and prenatal diagnosis: the Sardinian experience. Ciba Foundation Symposium1996;197:137-51.">Cao 1996</a>) and Greece (<a href="./references#CD010849-bbs2-0082" title="LoukopoulosD . Current status of thalassemia and the sickle cell syndromes in Greece. Seminars in Hematology1996;33(1):76-86.">Loukopoulos 1996</a>). </p> <p>In line with international policy recommendations, the UK Human Genetics Commission has recognised that since antenatal screening is currently already offered for genetic conditions such as sickle cell disease and thalassaemia, there are no ethical, legal or social issues with regards to the implementation of a preconception screening programme which would provide the advantage of improving reproductive choices (<a href="./references#CD010849-bbs2-0069" title="Human Genetics Commission. Increasing options, informing choice: A report on preconception genetic testing and screening. Human Genetics Commission2011.">Human Genetics Commission 2011</a>). </p> <p>In South‐East Asia, the Family Planning Association of Hong Kong has recognised the benefits of preconception screening of genetic risk due to the high prevalence of thalassaemia carriers, accounting for up to eight per cent of the local population (<a href="./references#CD010849-bbs2-0077" title="LauYL , ChanLC , ChanYY , HaSY , YeungCY , WayeJS , et al. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening. New England Journal of Medicine1997;336(18):1298-301.">Lau 1997</a>). </p> </section> <h3 class="title" id="CD010849-sec-0069">Implications for research</h3> <section id="CD010849-sec-0069"> <p>It has been suggested that the optimum evidence to evaluate the reproductive and psychological outcomes as a result of preconception screening compared to standard practice is a systematic review of RCTs, or a high‐quality RCT with a large enough sample size to ensure the control of potential confounding factors (<a href="./references#CD010849-bbs2-0110" title="UK National Screening Committee. Criteria for screening programmes. www.screening.nhs.uk/criteria (accessed 22 July 2014).">UK National Screening Committee 2003</a>). Such trials address methodological issues that are particularly associated with screening interventions such as ascertainment bias due to non‐randomisation, with individuals joining screening programmes tending to have healthier lifestyles and better adherence to interventions (<a href="./references#CD010849-bbs2-0105" title="SmithRA , MettlinCJ , EyreH . Methodologic issues in the evaluation of early detection programs. In: KufeDW , PollockRE , WeichselbaumRR , editors(s). Holland-Frei Cancer Medicine. 6th edition. Hamilton (ON): BC Decker, 2003.">Smith 2003</a>).  </p> <p>Previous observational studies and RCTs on preconception genetic risk assessment for thalassaemia, sickle cell disease, cystic fibrosis, or Tay‐Sachs disease have been limited by the duration of follow‐up and restricted to the assessment of psychological or knowledge outcomes. Indeed, none of the excluded studies identified in the searches for this review has evaluated reproductive outcomes. This is possibly related to the limited duration of follow‐up in these studies. Although preconception genetic carrier tests and screening have been shown to be highly accurate and efficient in determining carrier status (<a href="./references#CD010849-bbs2-0034" title="BachG , TomczakJ , RischN , EksteinJ . Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure. American Journal of Medical Genetics2001;99(1):70-5.">Bach 2001</a>; <a href="./references#CD010849-bbs2-0046" title="GrosseSD , BoyleCA , BotkinJR , ComeauAM , KharraziM , RosenfeldM , et al. Newborn screening for cystic fibrosis. Evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recommendations Report2004;53(RR-13):1-36.">CDC 2004</a>; <a href="./references#CD010849-bbs2-0095" title="PetersM , HeijboerH , SmiersF , GiordanoPC . Diagnosis and management of thalassaemia. BMJ2012;344:e228.">Peters 2012</a>; <a href="./references#CD010849-bbs2-0114" title="WeatherallD . ABC of clinical haematology: the hereditary anaemias. BMJ1997;314(7079):492-6.">Weatherall 1997</a>), the effectiveness of such interventions is to enable reproductive choice for carrier couples, which may, as a consequence, lead to reduced morbidity and mortality of the diseases. Therefore, reproductive outcomes are essential to addressing this question. Adequately‐powered RCTs assessing reproductive outcomes (number of affected children born with genetic conditions) and reproductive decision outcomes on future conception (termination, <i>in vitro</i> fertilisation, use of donor gametes, adoption, or refraining from having children) are ideal to better inform recommendations for clinical practice. Any self‐reported secondary outcome measures need to use validated instruments. These trials will require longer durations of follow‐up than previous studies, starting from pre‐pregnancy and lasting into the post‐natal period. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010849-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010849-sec-0008"></div> <p>A glossary of terms is available as an appendix (<a href="./appendices#CD010849-sec-0072">Appendix 1</a>). </p> <section id="CD010849-sec-0009"> <h3 class="title" id="CD010849-sec-0009">Description of the condition</h3> <p>Genetic medicine is expanding into almost every aspect of health care; reproductive risk assessment during the preconception period is a prime example. Identifying genetic risks before pregnancy or conception might produce significant benefits, such as providing information about the risk of having children with genetic conditions and thus giving couples or prospective parents the opportunity to make more informed reproductive decisions. It has been estimated that a couple has a baseline risk of 2% to 3% of having a child with a congenital or genetic disorder (<a href="./references#CD010849-bbs2-0108" title="TeeuwME , HennemanL , BochdanovitsZ , HeutinkP , KuikDJ , CornelandMC , et al. Do consanguineous parents of a child affected by an autosomal recessive disease have more DNA identical-by-descent than similarly-related parents with healthy offspring? Design of a case-control study. BMC Medical Genetics2010;11:113.">Teeuw 2010</a>). The probability of having an affected child increases when there is a family history of genetic disorders (<a href="./references#CD010849-bbs2-0103" title="ShapiraSK , DolanS . Genetic risks to the mother and the infant: assessment, counselling, and management. Maternal &amp; Child Health Journal2006;10(5):143-6.">Shapira 2006</a>; <a href="./references#CD010849-bbs2-0108" title="TeeuwME , HennemanL , BochdanovitsZ , HeutinkP , KuikDJ , CornelandMC , et al. Do consanguineous parents of a child affected by an autosomal recessive disease have more DNA identical-by-descent than similarly-related parents with healthy offspring? Design of a case-control study. BMC Medical Genetics2010;11:113.">Teeuw 2010</a>). Globally, about 6% of children are born with a serious birth defect of genetic or partially genetic origin (<a href="./references#CD010849-bbs2-0083" title="ChristiansonA , HowsonCP , ModellB . Global Report on Birth Defects. The hidden toll of dying and disabled children. Available from www.marchofdimes.org/materials/global-report-on-birth-defects-the-hidden-toll-of-dying-and-disabled-children-executive-summary.pdf 2006 (accessed 28 July 2021).">March of Dimes 2006</a>) with over 1800 genes linked to recessively inherited disorders (<a href="./references#CD010849-bbs2-0032" title="AntonarakisSE . Carrier screening for recessive disorders. Nature Revires Genetics2019;20(9):549-61. [DOI: 10.1038/s41576-019-0134-2]">Antonarakis 2019</a>).  </p> <p>Preconception risk assessment for autosomal recessive or X‐linked recessive genetic disorders would benefit couples who may be carriers. The most common examples of these autosomal recessive disorders are thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease. In these disorders, such carriers are usually asymptomatic; however, their child will be affected if he or she inherits the affected genes from both parents. All carrier couples have a 25% chance of having an affected child. These conditions have a high morbidity risk, are potentially life‐threatening and have a significant psychological impact not only on the affected child but also on their families or care givers. These diseases are also more prevalent in individuals of particular ethnic backgrounds (<a href="./references#CD010849-bbs2-0117" title="World Health Organization. Genes and Human Disease. www.who.int/genomics/public/geneticdiseases/en/index2.html (accessed 8 May 2013);(Publication no. 2007/19E). [ISBN: 978-90-5549-678-5]">WHO 2000</a>). X‐linked recessive genetic disorders include haemophilia A and B, and Duchenne muscular dystrophy. In these disorders, if the mother is a carrier, she has a 25% chance of having a son with the condition in each pregnancy (<a href="./references#CD010849-bbs2-0063" title="HaqueIS , LazarinGA , KangHP , EvansEA , GoldbergJD , WapnerRJ . Modeled fetal risk of genetic diseases identified by expanded carrier screening. JAMA2016;316(7):734-42.">Haque 2016</a>). </p> <p>In some countries, the need for medical care for children with these diseases, as well as psychological interventions to offer behavioural and emotional support, imposes a potentially high economic and public health burden (<a href="./references#CD010849-bbs2-0048" title="CornelMC , RigterT , JansenME , HennemanL . Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide. Journal of Community Genetics2021;12(2):257-65. [DOI: 10.1007/s12687-020-00488-y]">Cornel 2021</a>).  In view of the magnitude of these conditions and their implications for children and their families, there have been considerable efforts to identify the genetic reproductive risk for the four specified conditions and offer counselling and support to potential parents before the birth of an affected child. Women and couples at increased genetic risk, as well as healthcare professionals, have recognised the importance of preconception assessment to increase reproductive autonomy (<a href="./references#CD010849-bbs2-0041" title="BoultonM , CummingsC , WilliamsonR . The views of general practitioners on community carrier screening for cystic fibrosis. British Journal of General Practice1996;46(406):299-301.">Boulton 1996</a>; <a href="./references#CD010849-bbs2-0011" title="HennemanL , BramsenI , van der Ploeg, ten Kate, LP. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genetic Testing2002;6(3):195-202. HennemanL , BramsenI , van derPloegHM , AderHJ , van derHorstHE , GilleJJP , et al. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. Journal of Medical Genetics2001;38(10):695-703. HennemanL , BramsenI , vanKempenL , vanAckerMB , PalsG , van derHorstHE , et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics2003;6(1):5-13. LakemanPL , PlassAMC , HennemanL , BezemerPD , CornelMC , ten KateLP . Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine2008;10(11):820-30. ">Henneman 2001</a>; <a href="./references#CD010849-bbs2-0068" title="HoltkampKC , VosEM , RigterT , LakemanP , HennemanL , Cornel MC . Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape.. BMC Health Services Research2017;17(1):146. [DOI: 10.1186/s12913-017-2083-9]">Holtkamp 2017</a>; <a href="./references#CD010849-bbs2-0070" title="JanssensS , De PaepeA , BorryP . Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature. Journal of Community Genetics2014;5(1):13-29. [DOI: 10.1007/s12687-012-0131-z]">Janssens 2014</a>; <a href="./references#CD010849-bbs2-0081" title="LocockL , KaiJ . Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. British Journal of General Practice2008;58(548):161-8.">Locock 2008</a>; <a href="./references#CD010849-bbs2-0085" title="MassieJ , IoannouL , DelatyckiM . Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?Australia and New Zealand Journal of Obstetric and Gynaecology2014;54(6):503-09. [DOI: 10.1111/ajo.12255]">Massie 2014</a>; <a href="./references#CD010849-bbs2-0086" title="MennieM , CampbellH , ListonWA , BrockDJ . Attitudes of general practitioners to screening for cystic fibrosis. Journal of Medical Screening1998;5(1):11-5.">Mennie 1998</a>; <a href="./references#CD010849-bbs2-0096" title="PoppelaarsFAM , AderHJ , CornelMC , HennemanL , HermensRP , van derWalG , et al. Attitudes of potential providers towards preconceptional cystic fibrosis carrier screening. Journal of Genetic Counseling2004;13(1):31-44.">Poppelaars 2004</a>; <a href="./references#CD010849-bbs2-0113" title="WatsonEK , ShickleD , QureshiN , EmeryJ , AustokerJ . The 'new genetics' and primary care: GPs' view on their role and their educational needs. Family Practice1999;16(4):420-5.">Watson 1999</a>; <a href="./references#CD010849-bbs2-0118" title="WilleMC , WeitzB , KerperP , FrazierS . Advances in preconception genetic counselling. Journal of Perinatal &amp; Neonatal Nursing2004;18(1):28-40.">Wille 2004</a>). To date, the practical experience of reproductive genetic risk assessment for autosomal recessive disorders focuses mainly on the antenatal and newborn periods (<a href="./references#CD010849-bbs2-0097" title="QureshiN , ModellB , ModellM . Raising the profile of genetics in primary care. Nature Reviews Genetics2004;5(10):783-90.">Qureshi 2004</a>). Identifying genetic reproductive risk during the antenatal period leaves the couple a short period of time to make difficult or limited choices, such as terminating the pregnancy or continuing with the pregnancy and caring for the affected child (<a href="./references#CD010849-bbs2-0055" title="DormandyE , GullifordMC , ReidEP , BrownK , MarteauTM . Delay between pregnancy confirmation and sickle cell and thalassaemia screening: a population-based cohort study. British Journal of General Practice2008;58(548):154-9.">Dormandy 2008</a>). Identifying couples who have confirmed genetic carrier status before conception provides an opportunity for individuals or couples to make fully informed reproductive choices including not having children, PGT using donor gametes, arranging early prenatal diagnosis and antenatal care and also considering adoption of a child (<a href="./references#CD010849-bbs2-0072" title="JonesSL , FallonLA . Reproductive options for individuals at risk for transmission of a genetic disorder. Journal of Obstetric, Gynecologic, &amp; Neonatal Nursing2002;31(2):193-9.">Jones 2002</a>; <a href="./references#CD010849-bbs2-0118" title="WilleMC , WeitzB , KerperP , FrazierS . Advances in preconception genetic counselling. Journal of Perinatal &amp; Neonatal Nursing2004;18(1):28-40.">Wille 2004</a>).  </p> <section id="CD010849-sec-0010"> <h4 class="title">Thalassaemia</h4> <p>According to the March of Dimes Birth Defects Foundation, an estimated 307,900 children are born annually with major haemoglobin disorders, the most common being thalassaemia and sickle cell disease (<a href="./references#CD010849-bbs2-0083" title="ChristiansonA , HowsonCP , ModellB . Global Report on Birth Defects. The hidden toll of dying and disabled children. Available from www.marchofdimes.org/materials/global-report-on-birth-defects-the-hidden-toll-of-dying-and-disabled-children-executive-summary.pdf 2006 (accessed 28 July 2021).">March of Dimes 2006</a>). Thalassaemia is characterised by the defects or absence of synthesis in one of the two globin chains (α or β) which form the normal adult human haemoglobin molecule; this leads to haemolytic anaemia (<a href="./references#CD010849-bbs2-0095" title="PetersM , HeijboerH , SmiersF , GiordanoPC . Diagnosis and management of thalassaemia. BMJ2012;344:e228.">Peters 2012</a>). Thalassaemia can be diagnosed by measuring fractions of haemoglobin A and haemoglobin F with high‐performance liquid chromatography (HPLC) or electrophoresis. In addition, DNA analysis is required to detect an α or β globin chain mutation (<a href="./references#CD010849-bbs2-0095" title="PetersM , HeijboerH , SmiersF , GiordanoPC . Diagnosis and management of thalassaemia. BMJ2012;344:e228.">Peters 2012</a>). It is estimated that between two and five per cent of the world's population are carriers and this is more prevalent in the Mediterranean, the Middle East, South and East Asia, and the Pacific, with carrier rates ranging from two per cent to 19 per cent (<a href="https://archie.cochrane.org/sections/documents/view?version=z1801291111170522035412241227527&amp;format=JATS#REF-Modell-2001" target="_blank">Modell 2001</a>; <a href="./references#CD010849-bbs2-0083" title="ChristiansonA , HowsonCP , ModellB . Global Report on Birth Defects. The hidden toll of dying and disabled children. Available from www.marchofdimes.org/materials/global-report-on-birth-defects-the-hidden-toll-of-dying-and-disabled-children-executive-summary.pdf 2006 (accessed 28 July 2021).">March of Dimes 2006</a>). Because of founder effect, carrier rates have also increased in countries that previously had low prevalences (<a href="./references#CD010849-bbs2-0049" title="CousensNE , GaffCL , MetcalfeSA , DelatyckiMB . Carrier screening for beta-thalassaemia: a review of international practice.. European Journal of Human Genetics2010;18(10):1077-83. [DOI: 10.1038/ejhg.2010.90]">Cousens 2010</a>). Morbidity is related to severe anaemia and an affected child will require lifelong blood transfusions. Multiple blood transfusions may eventually result in iron overload and potentially cause heart failure, infection, hypogonadism, infertility, diabetes mellitus, and hypothyroidism. Affected individuals may die prematurely unless given optimal medical management. In individuals with thalassaemia and their families or caregivers, psychosocial problems have also been reported, for example, stigmatisation, isolation, family adjustment, coping with school and education, and social interaction (<a href="./references#CD010849-bbs2-0060" title="GharaibehH , AmarnehBH , ZamzamSZ . The psychological burden of patients with beta thalassemia major in Syria. Pediatrics International2009;51(5):630-6.">Gharaibeh 2009</a>; <a href="./references#CD010849-bbs2-0098" title="RatipS , ModellB . Psychological and sociological aspects of the thalassemias. Seminars in Hematology1996;33(1):53-65.">Ratip 1996</a>; <a href="./references#CD010849-bbs2-0109" title="TelferP , ConstantinidouG , AndreouP , ChristouS , ModellB , AngastiniotisM . Quality of life in thalassemia. Annals of the New York Academy of Sciences2005;1054(1):273-82.">Telfer 2005</a>). </p> </section> <section id="CD010849-sec-0011"> <h4 class="title">Sickle cell disease</h4> <p>Sickle cell disease is caused by a mutation in the haemoglobin gene (β<sup>S</sup>) which individuals inherit from both parents (<a href="./references#CD010849-bbs2-0114" title="WeatherallD . ABC of clinical haematology: the hereditary anaemias. BMJ1997;314(7079):492-6.">Weatherall 1997</a>). The WHO estimates that sickle cell disease affects 275,000 conceptions each year globally (<a href="./references#CD010849-bbs2-0090" title="ModellB , DarlisonM . Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization2008;86(6):480-7.">Modell 2008</a>; <a href="./references#CD010849-bbs2-0119" title="YusufHR , Lloyd-PuryearMA , GrantAM , ParkerCS , CrearyMS , AtrashHK . Sickle cell disease: the need for a public health agenda. American Journal of Preventive Medicine2011;41(6):376-83.">Yusuf 2011</a>). Diagnosis is confirmed using HPLC or electrophoresis with the detection of haemoglobin S and C fraction. It affects mainly individuals of African origin but is also found in Indian and some Mediterranean populations. The reported prevalence of carrier frequency ranges from one to 40 per cent, depending on the population group. The condition causes the red blood cells to have a sickle shape which results in premature haemolysis and can lead to life‐threatening acute and chronic vaso‐occlusion, including renal and cardiovascular complications. Individuals with this condition are also susceptible to serious septicaemia. Like thalassaemia, individuals and their families are also confronted with psychosocial challenges which include the disruption of school and work, social isolation and loneliness, stigmatisation, bullying, and rejection by peers (<a href="./references#CD010849-bbs2-0035" title="BarbarinOA , WhittenCF , BondS , Conner-WarrenR . The social and cultural of coping with sickle cell disease: the role of financial hardship in adjustment to sickle cell disease. Journal of Black Psychology1999;23(3):294-315.">Barbarin 1999</a>). Recently, there has been a new development in the treatment of sickle cell disease, somatic genome editing which is currently being studied (<a href="./references#CD010849-bbs2-0039" title="BonhamVL , SmilanLE . Somatic Genome Editing in Sickle Cell Disease: Rewriting a More Just Future. North Carolina Law Review2019;97:1093.">Bonham 2019</a>). </p> </section> <section id="CD010849-sec-0012"> <h4 class="title">Cystic fibrosis</h4> <p>Cystic fibrosis is caused by a mutation in the gene cystic fibrosis transmembrane conductance regulator <i>(CFTR)</i> ; more than 2000 <i>CFTR</i> mutations have now been identified (<a href="./references#CD010849-bbs2-0036" title="BareilC , BergougnouxA . CFTR gene variants, epidemiology and molecular pathology,. Archives de Pédiatrie2020;27(1):8-12. [DOI: 10.1016/S0929-693X(20)30044-0.]">Bareil 2020</a>). Diagnosis of cystic fibrosis is indicated by phenotypic features (chronic sino‐pulmonary disease, gastrointestinal and nutritional abnormalities, obstructive azoospermia and salt‐loss syndromes), a family history of cystic fibrosis or a positive newborn screening test, together with laboratory evidence of a <i>CFTR</i> abnormality. Abnormalities in the <i>CFTR</i> genes can be identified by elevated sweat chloride concentrations (sweat test), identification of two CFTR mutations, or <i>in vivo</i> demonstration of characteristic abnormalities in ion transport across the nasal epithelium. Carriers are confirmed by the identification of a CFTR mutation from the blood or saliva (<a href="./references#CD010849-bbs2-0046" title="GrosseSD , BoyleCA , BotkinJR , ComeauAM , KharraziM , RosenfeldM , et al. Newborn screening for cystic fibrosis. Evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recommendations Report2004;53(RR-13):1-36.">CDC 2004</a>). </p> <p>Cystic fibrosis is most common among people of European descent with a carrier frequency of 1 in 25 (<a href="./references#CD010849-bbs2-0091" title="MurrayJ , CuckleH , TaylorG , LittlewoodJ , HewisonJ . Screening for cystic fibrosis. Health Technology Assessment1999;3(8).">Murray 1999</a>). This condition is commonly associated with recurrent pulmonary infections, which potentially lead to bronchiectasis and atelectasis, and also pancreatic exocrine insufficiency. There is currently no cure for the disease, with treatment mainly aimed at improving a person's quality of life. However, in the past years, significant progress has been made, in particular, regarding <i>CFTR</i>‐directed therapeutics (<a href="./references#CD010849-bbs2-0094" title="PatelSD , BonoTR , RoweSM , SolomonGM . CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways. European Respiratory Review2020;29(156):190068. [DOI: 10.1183/16000617.0068-2019]">Patel 2020</a>) The need for emotional and social adjustment is a significant psychosocial consequence for people with cystic fibrosis (<a href="./references#CD010849-bbs2-0042" title="BregnballeV , ThastumM , SchiøtzPO . Psychosocial problems in children with cystic fibrosis. Acta Paediatrica2007;96(1):58-61.">Bregnballe 2007</a>; <a href="./references#CD010849-bbs2-0061" title="GlasscoeCA , QuittnerAL . Psychological interventions for people with cystic fibrosis and their families. Cochrane Database of Systematic Reviews2008, Issue 3. Art. No: CD003148. [DOI: 10.1002/14651858.CD003148.pub2]">Glasscoe 2008</a>).  </p> </section> <section id="CD010849-sec-0013"> <h4 class="title">Tay‐Sachs disease</h4> <p>Tay‐Sachs disease is caused by a genetic mutation in the α chains of the hexosaminidase A (Hex A) isozyme in the gangliosides in nerve cells of the brain (<a href="./references#CD010849-bbs2-0034" title="BachG , TomczakJ , RischN , EksteinJ . Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure. American Journal of Medical Genetics2001;99(1):70-5.">Bach 2001</a>). The disease is diagnosed by measuring the activity of hexosaminidase A and further identification of a genetic mutation in Hex A (<a href="./references#CD010849-bbs2-0024" title="American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. ACOG Committee Opinion No. 6912017;129(3):41-55.">ACOG Committee Opinion 2017</a>). It is most prevalent in the Ashkenazi Jewish populations, with a carrier frequency of around 1 in 30 (<a href="./references#CD010849-bbs2-0024" title="American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. ACOG Committee Opinion No. 6912017;129(3):41-55.">ACOG Committee Opinion 2017</a>). The condition leads to a progressive deterioration of mental and physical abilities. Death usually occurs before five years of age. At present, there is no cure or available treatment. </p> </section> </section> <section id="CD010849-sec-0014"> <h3 class="title" id="CD010849-sec-0014">Description of the intervention</h3> <p>Women and their partners can be assessed during the preconception period to identify if they are carriers of one of these four autosomal recessive conditions, which represent the most common autosomal recessive conditions globally. Cystic fibrosis is most common in Northern European populations; sickle cell disease and thalassaemia are most common non‐Northern European populations, and Tay‐Sachs disease is most common in individuals of Ashkenazi Jewish ancestry. Approaches to improve health outcomes and reproductive choice in couples who carry these genetic conditions should be generalisable to other, but rarer, autosomal recessive conditions. In populations with high carrier rates or significant burden of affected individuals, or both, carrier screening may be offered during preconception to all women in some healthcare settings (<a href="./references#CD010849-bbs2-0024" title="American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. ACOG Committee Opinion No. 6912017;129(3):41-55.">ACOG Committee Opinion 2017</a>). More commonly, women and their partners may be assessed on the need for carrier testing. This assessment would be based firstly on a review of the family history for any of the autosomal recessive conditions or their carrier status; and, secondly, on the ethnic origin of the woman and her partner (<a href="./references#CD010849-bbs2-0056" title="DysonSM , CulleyLA , GillC , HubbardS , KennefickA , MorrisP , et al. Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: A randomized controlled trial of two questionnaires. Ethnicity and Health2006;11(2):169-89.">Dyson 2006</a>). This assessment of ancestry will identify if the individual originates from an ethnic group with a greater probability of being a healthy carrier of any of the four autosomal recessive disorders; for example, those with Ashkenazi Jewish ancestry are more likely to carry Tay‐Sachs disease, whilst those of African descent may carry sickle cell trait. The benefits of recording family history as one of the components of preconception health checks have been reported in previous observational community‐based studies for a broad range of genetic conditions (<a href="./references#CD010849-bbs2-0050" title="CzeizelAE . Experience of the Hungarian Preconception Service between 1984 and 2010. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2012;161(1):18-25.">Czeizel 2012</a>; <a href="./references#CD010849-bbs2-0104" title="CornelMC , GoodmanS , HennemanL . Genetic health care before conception. In: ShaweJ , SteegersE , VerbiestS , editors(s). Preconception Health and Care: A Life Course Approach. 1st edition. Springer International Publishing, 2020:35-52. [DOI: 10.1007/978-3-030-31753-9_4]">Shaw 2020</a>). </p> <p>Overall, previous interventions have involved genetic carrier testing or screening (with or without educational support and genetic counselling) or both. There is often confusion between the terms genetic carrier testing and screening (<a href="./references#CD010849-bbs2-0093" title="Nuffield Council on Bioethics. Genetic screening: ethical issues. Nuffield Council on Bioethics1993. [ISBN: 0 9522701 0 2]">Nuffield Council on Bioethics 1993</a>). Genetic carrier testing refers to the testing of individuals to determine the presence or absence of the carrier status (<a href="./references#CD010849-bbs2-0069" title="Human Genetics Commission. Increasing options, informing choice: A report on preconception genetic testing and screening. Human Genetics Commission2011.">Human Genetics Commission 2011</a>). This testing could, for example, be in the context of a family history of the autosomal recessive condition or relevant ethnicity. On the other hand, genetic carrier screening involves offering or testing the whole population group irrespective of individual risk (<a href="./references#CD010849-bbs2-0045" title="CastellaniC , Macek M Jr, CassimanJJ , DuffA , MassieJ , ten KateLP , et al. Benchmarks for cystic fibrosis carrier screening: a European consensus document. Journal of Cystic Fibrosis2010;9(3):165-78.">Castellani 2010</a>; <a href="./references#CD010849-bbs2-0069" title="Human Genetics Commission. Increasing options, informing choice: A report on preconception genetic testing and screening. Human Genetics Commission2011.">Human Genetics Commission 2011</a>). Both genetic carrier testing and screening involve the analysis of blood, tissue or bodily fluid samples. </p> <p>With regards to the actual genetic carrier tests, currently either HPLC or electrophoresis is used to detect haemoglobin variants and to confirm carrier status for thalassaemia and sickle cell disease (<a href="./references#CD010849-bbs2-0092" title="NHS Sickle Cell and Thalassaemia  Screening Programme. United Kingdom National Screening Programmes Information Strategy. http://sct.screening.nhs.uk (accessed 8 January 2013).">NHS SCT Screening Programme 2013</a>). Carrier status for cystic fibrosis is confirmed by analysing the mutations in the gene CFTR, using DNA commonly obtained from white blood cells, mouthwashes and buccal swabs (<a href="./references#CD010849-bbs2-0091" title="MurrayJ , CuckleH , TaylorG , LittlewoodJ , HewisonJ . Screening for cystic fibrosis. Health Technology Assessment1999;3(8).">Murray 1999</a>). Confirmation of Tay‐Sachs disease carrier status comprises of molecular analysis to detect genetic mutations in the α chains of the hexosaminidase A (Hex A) isozyme. To improve the detection rate, this should be combined with biochemical tests (<a href="./references#CD010849-bbs2-0024" title="American College of Obstetricians and Gynecologists. Carrier screening for genetic conditions. ACOG Committee Opinion No. 6912017;129(3):41-55.">ACOG Committee Opinion 2017</a>). </p> <p>For each condition, as well as confirmed carrier status identified by genetic carrier tests, there are other laboratory investigations that could indicate a probable carrier state. A microcytic or hypochromic blood picture, or both, without anaemia suggests a probable thalassaemia carrier, whilst a probable sickle cell carrier is indicated by a positive sickle solubility test. Elevated sodium chloride levels in sweat can indicate a probable cystic fibrosis carrier state. </p> <p>At present, there is no formal or standard recommendation that fully addresses preconception genetic risk assessment (<a href="./references#CD010849-bbs2-0092" title="NHS Sickle Cell and Thalassaemia  Screening Programme. United Kingdom National Screening Programmes Information Strategy. http://sct.screening.nhs.uk (accessed 8 January 2013).">NHS SCT Screening Programme 2013</a>). There is variability in how preconception genetic risk assessment is offered across countries. For example, screening for haemoglobinopathies is offered in pre‐marital clinics (<a href="./references#CD010849-bbs2-0049" title="CousensNE , GaffCL , MetcalfeSA , DelatyckiMB . Carrier screening for beta-thalassaemia: a review of international practice.. European Journal of Human Genetics2010;18(10):1077-83. [DOI: 10.1038/ejhg.2010.90]">Cousens 2010</a>; <a href="./references#CD010849-bbs2-0101" title="SamavatA , ModellB . Iranian national thalassaemia screening programme. BMJ2004;329(7475):1134.">Samavat 2004</a>), whereas, screening for any reproductive genetic disorder may be offered opportunistically in a range of settings such as family planning clinics (<a href="./references#CD010849-bbs2-0052" title="Delatycki, MB, Alkuraya, F, Archibald, A, et al. International perspectives on the implementation of reproductive carrier screening.. Prenatal Diagnosis2020;20:301-10. [DOI: 10.1002/pd.5611]">Delatycki 2019</a>; <a href="./references#CD010849-bbs2-0113" title="WatsonEK , ShickleD , QureshiN , EmeryJ , AustokerJ . The 'new genetics' and primary care: GPs' view on their role and their educational needs. Family Practice1999;16(4):420-5.">Watson 1999</a>). Similarly, in current clinical practice, preconception risk assessment is not offered systematically, but most commonly offered opportunistically, for example when the issue is brought up by the couple or through family history (<a href="./references#CD010849-bbs2-0065" title="HeyesT , LongS , MathersN . Preconception care. Practice and beliefs of primary care workers. Family Practice2004;21(1):22-7.">Heyes 2004</a>).  </p> <p><b><i>Preconception expanded carrier screening</i> </b> </p> <p>In recent years, next‐generation sequencing has enabled the screening of hundreds of genetic conditions in one panel simultaneously, including the four conditions described above, as compared to single gene‐by‐gene carrier screening offered traditionally (<a href="./references#CD010849-bbs2-0025" title="American College of Obstetricians and Gynecologists. Carrier screening in the age of genomic medicine. ACOG Committee Opinion No. 6902017;129(3):595-6.">ACOG Committee Opinion 2017 (reaffirmed 2020)</a>; <a href="./references#CD010849-bbs2-0062" title="GrodyWW , ThompsonBH , GreggAR , BeanLH , MonaghanKG , SchneiderA , et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genetic Medicine2013;15(6):482-83. [DOI: 10.1038/gim.2013.47]">Grody 2013</a>). Expanded carrier screening allows testing of all individuals regardless of ancestry, thereby potentially reducing the risk of stigmatisation of specific groups and a more pragmatic approach to preconception carrier screening. The Superior Health Council of Belgium has proposed an expanded carrier screening for autosomal and X‐linked recessive conditions to be offered preconceptionally (<a href="./references#CD010849-bbs2-0107" title="Superior Health Council Belgium. Advisory report of the superior health council: expanded carrier screening in a reproductive context. Towards a Responsible Implementation in the Healthcare System. Available from www.health.belgium.be/fr/avis‐92402017;9240:1-26.">Superior Health Council Belgium 2017</a>). Although there is no firm or standard recommendation for preconception expanded carrier screening, professional bodies including the European Society of Human Genetics have published recommendations on how to responsibly implement expanded carrier screening (<a href="./references#CD010849-bbs2-0025" title="American College of Obstetricians and Gynecologists. Carrier screening in the age of genomic medicine. ACOG Committee Opinion No. 6902017;129(3):595-6.">ACOG Committee Opinion 2017 (reaffirmed 2020)</a>). Currently, the Australian Reproductive Genetic Carrier Screening Project (“Mackenzie’s Mission”) is developing a carrier screening model which involves gene selection for carrier screening panel, evaluation of uptake, reproductive decisions, ethical and psychosocial aspects as well as cost‐effectiveness (<a href="./references#CD010849-bbs2-0052" title="Delatycki, MB, Alkuraya, F, Archibald, A, et al. International perspectives on the implementation of reproductive carrier screening.. Prenatal Diagnosis2020;20:301-10. [DOI: 10.1002/pd.5611]">Delatycki 2019</a>; <a href="./references#CD010849-bbs2-0075" title="KirkEP , OngR , BoggsK , HardyT , RighettiS , KamienB , et al. Gene selection for the Australian Reproductive Genetic Carrier Screening Project (“Mackenzie’s Mission”). European Journal of Human Genetics2021;29:79-87. [DOI: 10.1038/s41431-020-0685-x]">Kirk 2021</a>). </p> </section> <section id="CD010849-sec-0015"> <h3 class="title" id="CD010849-sec-0015">How the intervention might work</h3> <p>In the specified autosomal recessive disorders (thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease), preconception genetic risk assessment ensures at‐risk couples, in which both the women and her partner are carriers of the specified conditions, are aware that they have a one‐in‐four chance of an affected child prior to pregnancy, enabling them to achieve fully informed reproductive autonomy (<a href="./references#CD010849-bbs2-0043" title="CannonJ , Van SteijvoortE , BorryP , ChokoshviliD . How does carrier status for recessive disorders influence reproductive decisions? A systematic review of the literature. Expert Review of Molecular Diagnostic2019;19(12):1117-29. [DOI: 10.1080/14737159.2020.1690456]">Cannon 2019</a>; <a href="./references#CD010849-bbs2-0047" title="ChristieLM , IngretAJ , TurnerGM . Outcomes of a cystic fibrosis carrier testing clinic for couples. Medical Journal of Australia2009;191(9):499-501.">Christie 2009</a>; <a href="./references#CD010849-bbs2-0050" title="CzeizelAE . Experience of the Hungarian Preconception Service between 1984 and 2010. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2012;161(1):18-25.">Czeizel 2012</a>; <a href="./references#CD010849-bbs2-0078" title="Lena-RussoD , BadensC , AubinaudM , MeronoF , PaolassoC , MartiniN , et al. Outcome of a school screening programme for carriers of haemoglobin disease. Journal of Medical Screening2002;9(2):67-9.">Lena‐Russo 2002</a>; <a href="./references#CD010849-bbs2-0084" title="MassieJ , PetrouV , ForbesR , CurnowL , IoannouL , BankierA , et al. Population-based carrier screening for cystic fibrosis in Victoria: The first three years experience. Australian and New Zealand Journal of Obstetrics and Gynaecology2009;49(5):484-9.">Massie 2009</a>). This offers the at‐risk couples the opportunity to consider the full range of reproductive options (<a href="./references#CD010849-bbs2-0040" title="BorryP , HennemanL , LakemanP , ten KateLP , CornelMC , HowardHC . Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Human Reproduction2011;26(5):972-7.">Borry 2011</a>); for instance, couples may choose to have <i>in vitro</i> fertilisation (IVF) with pre‐implantation genetic testing (PGT), use donor gametes, adopt a child or remain childless (<a href="./references#CD010849-bbs2-0069" title="Human Genetics Commission. Increasing options, informing choice: A report on preconception genetic testing and screening. Human Genetics Commission2011.">Human Genetics Commission 2011</a>; <a href="./references#CD010849-bbs2-0072" title="JonesSL , FallonLA . Reproductive options for individuals at risk for transmission of a genetic disorder. Journal of Obstetric, Gynecologic, &amp; Neonatal Nursing2002;31(2):193-9.">Jones 2002</a>; <a href="./references#CD010849-bbs2-0118" title="WilleMC , WeitzB , KerperP , FrazierS . Advances in preconception genetic counselling. Journal of Perinatal &amp; Neonatal Nursing2004;18(1):28-40.">Wille 2004</a>). These options are not available to couples who are only made aware of their reproductive genetic risk during the pregnancy. Of equal importance, if couples who have already been informed of their risk, decide to carry on with pregnancy they may consider and be offered prenatal diagnosis earlier in pregnancy. This enables the option of termination in early gestation or can enhance preparation for foetal and maternal well‐being throughout pregnancy, preparation following the birth of an infant, and postnatal support. (<a href="./references#CD010849-bbs2-0118" title="WilleMC , WeitzB , KerperP , FrazierS . Advances in preconception genetic counselling. Journal of Perinatal &amp; Neonatal Nursing2004;18(1):28-40.">Wille 2004</a>). If the carrier testing is implemented in the antenatal period, all of these decisions are delayed (<a href="./references#CD010849-bbs2-0097" title="QureshiN , ModellB , ModellM . Raising the profile of genetics in primary care. Nature Reviews Genetics2004;5(10):783-90.">Qureshi 2004</a>). With regards to family history assessment, participants have acknowledged that this intervention enables pregnancy planning (<a href="./references#CD010849-bbs2-0100" title="RoseP , HummE , HeyK , JonesL , HusonSM . Family history taking and genetic counselling in primary care. Family Practice1999;16(1):78‐83.">Rose 1999</a>) and early identification of couples at reproductive genetic risk (<a href="./references#CD010849-bbs2-0050" title="CzeizelAE . Experience of the Hungarian Preconception Service between 1984 and 2010. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2012;161(1):18-25.">Czeizel 2012</a>). </p> <p>While the aim of preconception genetic risk assessment is to enable informed reproductive choices, in communities where families are affected by a high burden of disease, prevention of the birth prevalence of disease seemed appropriate (<a href="./references#CD010849-bbs2-0053" title="De WertGM , DondorpWJ , KnoppersBM . Preconception care and genetic risk: ethical issues. Journal of Community Genetics2012;3(3):221-28. [DOI: 10.1007/s12687-011-0074-9]">de Wert 2012</a>). At a societal level, preconception carrier state identification has reduced the rate of affected births (<a href="./references#CD010849-bbs2-0030" title="AngastiniotisM , ModellB . Global epidemiology of haemoglobin disorders. Annals of the New York Academy of Sciences1998;850:251-69.">Angastiniotis 1998</a>; <a href="./references#CD010849-bbs2-0043" title="CannonJ , Van SteijvoortE , BorryP , ChokoshviliD . How does carrier status for recessive disorders influence reproductive decisions? A systematic review of the literature. Expert Review of Molecular Diagnostic2019;19(12):1117-29. [DOI: 10.1080/14737159.2020.1690456]">Cannon 2019</a>; <a href="./references#CD010849-bbs2-0101" title="SamavatA , ModellB . Iranian national thalassaemia screening programme. BMJ2004;329(7475):1134.">Samavat 2004</a>). Although it is estimated that preconception screening programmes worldwide have caused a small decrease in affected births for haemoglobin disorders from 2.7 per 1000 conceptions to 2.55 per 1000 conceptions over a five‐year period from 1998 to 2003, more data and across all common autosomal recessive conditions need to be explored (<a href="./references#CD010849-bbs2-0090" title="ModellB , DarlisonM . Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization2008;86(6):480-7.">Modell 2008</a>). Similarly, early observational studies involving genetic carrier screening programmes for Tay‐Sachs disease and thalassaemia in Canada and France carried out in high school students were associated with an increased rate of early prenatal diagnosis and termination of affected pregnancies (<a href="./references#CD010849-bbs2-0078" title="Lena-RussoD , BadensC , AubinaudM , MeronoF , PaolassoC , MartiniN , et al. Outcome of a school screening programme for carriers of haemoglobin disease. Journal of Medical Screening2002;9(2):67-9.">Lena‐Russo 2002</a>; <a href="./references#CD010849-bbs2-0087" title="MitchellJJ , CapuaA , ClowC . Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and β-Thalassemia disease carriers in high schools. American Journal of Medical Genetics1996;59:793-8.">Mitchell 1996</a>; <a href="./references#CD010849-bbs2-0120" title="ZeesmanS , ClowCL , CartierL , ScriverCR . A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. American Journal of Medical Genetics1984;18(4):769-78.">Zeesman 1984</a>). In Cyprus and Iran, the prevalence of thalassaemia has decreased tremendously with the introduction of mandatory pre‐marital genetic carrier screening programmes (<a href="./references#CD010849-bbs2-0026" title="AlswaidiFM , O'BrienSJ . Premarital screening programmes for haemoglobinopathies, HIV and hepatitis viruses: review and factors affecting their success. Journal of Medical Screening2009;16(1):22-8.">Alswaidi 2009</a>; <a href="./references#CD010849-bbs2-0030" title="AngastiniotisM , ModellB . Global epidemiology of haemoglobin disorders. Annals of the New York Academy of Sciences1998;850:251-69.">Angastiniotis 1998</a>; <a href="./references#CD010849-bbs2-0101" title="SamavatA , ModellB . Iranian national thalassaemia screening programme. BMJ2004;329(7475):1134.">Samavat 2004</a>). In Hungary, preconception screening has resulted in improved identification of carrier couples and access to genetic counselling services (<a href="./references#CD010849-bbs2-0050" title="CzeizelAE . Experience of the Hungarian Preconception Service between 1984 and 2010. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2012;161(1):18-25.">Czeizel 2012</a>). The introduction of preconception expanded genetic screening allows for the detection of more carriers and carrier couples and potentially maximises opportunities for reproductive autonomy with a much wider array of reproductive risks; however, it has its own ethical, legal and social challenges (<a href="./references#CD010849-bbs2-0112" title="van derHoutS , HoltkampKC , HennemanL , deWertG , Dondorp WJ. Advantages of expanded universal carrier screening: what is at stake?European Journal of Human Genetics2016;1:17-21.">van der Hout 2016</a>). </p> </section> <section id="CD010849-sec-0016"> <h3 class="title" id="CD010849-sec-0016">Why it is important to do this review</h3> <p>While a number of observational studies have reported the potential benefits of preconception risk assessment for genetic conditions in general (<a href="./references#CD010849-bbs2-0050" title="CzeizelAE . Experience of the Hungarian Preconception Service between 1984 and 2010. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology2012;161(1):18-25.">Czeizel 2012</a>), and specifically for cystic fibrosis (<a href="./references#CD010849-bbs2-0047" title="ChristieLM , IngretAJ , TurnerGM . Outcomes of a cystic fibrosis carrier testing clinic for couples. Medical Journal of Australia2009;191(9):499-501.">Christie 2009</a>; <a href="./references#CD010849-bbs2-0084" title="MassieJ , PetrouV , ForbesR , CurnowL , IoannouL , BankierA , et al. Population-based carrier screening for cystic fibrosis in Victoria: The first three years experience. Australian and New Zealand Journal of Obstetrics and Gynaecology2009;49(5):484-9.">Massie 2009</a>), haemoglobinopathies (<a href="./references#CD010849-bbs2-0044" title="CaoA , RosatelliMC , GallanelloR . Control of beta-thalassaemia by carrier screening, genetic counselling, and prenatal diagnosis: the Sardinian experience. Ciba Foundation Symposium1996;197:137-51.">Cao 1996</a>) and Tay‐Sachs disease (<a href="./references#CD010849-bbs2-0087" title="MitchellJJ , CapuaA , ClowC . Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and β-Thalassemia disease carriers in high schools. American Journal of Medical Genetics1996;59:793-8.">Mitchell 1996</a>), as with other programmes for genetic testing or screening, this has potential adverse effects. Genetic assessment for reproductive risk has been linked to psychological distress such as anxiety; however, the raised anxiety was a transient phenomenon (<a href="./references#CD010849-bbs2-0033" title="ArchibaldAD , WilfordBS . Population carrier screening: psychological impact. Encyclopedia of Life Sciences2011. [DOI: 10.1002/9780470015902.a0005641.pub2]">Archibald 2011</a>; <a href="./references#CD010849-bbs2-0037" title="BekkerH , DennissG , ModellM , BobrowM , MarteauT . The impact of population based screening for carriers of cystic fibrosis. Journal of Medical Genetics1994;31(5):364-8.">Bekker 1994</a>). Further, it has been reported that carrier status may be associated with a poor perception of health (<a href="./references#CD010849-bbs2-0011" title="HennemanL , BramsenI , van der Ploeg, ten Kate, LP. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genetic Testing2002;6(3):195-202. HennemanL , BramsenI , van derPloegHM , AderHJ , van derHorstHE , GilleJJP , et al. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. Journal of Medical Genetics2001;38(10):695-703. HennemanL , BramsenI , vanKempenL , vanAckerMB , PalsG , van derHorstHE , et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics2003;6(1):5-13. LakemanPL , PlassAMC , HennemanL , BezemerPD , CornelMC , ten KateLP . Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine2008;10(11):820-30. ">Henneman 2001</a>) and may have an impact on the carrier's relationships with their partner (<a href="./references#CD010849-bbs2-0058" title="FanosJH , JohnsonJP . Barriers to carrier testing for adult cystic fibrosis sibs: the importance of not knowing. American Journal of Medical Genetics1995;59(1):85-91.">Fanos 1995</a>). Although the occurrence is low, social impacts such as stigmatisation and discrimination have been reported with mandatory carrier screening (<a href="./references#CD010849-bbs2-0038" title="BonhamVL , DoverGJ , BrodyLC . Screening student athletes for sickle cell trait: a social and clinical experiment. New England Journal of Medicine2010;363(11):997-9.">Bonham 2010</a>; <a href="./references#CD010849-bbs2-0074" title="KenenRH , SchmidtRM . Stigmatization of carrier status: social implications of heterozygote genetic screening programs. American Journal of Public Health1978;68(11):1116-20.">Kenen 1978</a>; <a href="./references#CD010849-bbs2-0115" title="WhittenCF . Sickle-cell programming: an imperilled promise. New England Journal of Medicine1973;288(6):318-9.">Whitten 1973</a>). Despite these reported adverse effects, there are numerous psychological benefits including the opportunity for informed decision‐making and reproductive autonomy in prospective parents (<a href="./references#CD010849-bbs2-0031" title="AnidoA , CarlsonLM , TaftL , ShermanSL . Women's attitudes toward testing for fragile X carrier status: a qualitative analysis. Journal of Genetic Counselling2005;14(4):295-306.">Anido 2005</a>; <a href="./references#CD010849-bbs2-0033" title="ArchibaldAD , WilfordBS . Population carrier screening: psychological impact. Encyclopedia of Life Sciences2011. [DOI: 10.1002/9780470015902.a0005641.pub2]">Archibald 2011</a>; <a href="./references#CD010849-bbs2-0043" title="CannonJ , Van SteijvoortE , BorryP , ChokoshviliD . How does carrier status for recessive disorders influence reproductive decisions? A systematic review of the literature. Expert Review of Molecular Diagnostic2019;19(12):1117-29. [DOI: 10.1080/14737159.2020.1690456]">Cannon 2019</a>; <a href="./references#CD010849-bbs2-0080" title="LewisC , SkirtonH , JonesR . Reproductive empowerment: The main motivator and outcome of carrier testing. Journal of Health Psychology2011;17(4):567-78.">Lewis 2011</a>). </p> <p>With regards to the economic implications, as for other programmes for genetic testing and screening, there is an opportunity cost for redistributing resources from medical care to preconception risk assessment (<a href="./references#CD010849-bbs2-0116" title="WilsonJMG , JungnerG . Principles and practice of screening for disease. Geneva: World Health Organization, 1968.">WHO 1968</a>). Addressing cost‐effectiveness in preconception carrier screening can be ethically sensitive (<a href="./references#CD010849-bbs2-0048" title="CornelMC , RigterT , JansenME , HennemanL . Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwide. Journal of Community Genetics2021;12(2):257-65. [DOI: 10.1007/s12687-020-00488-y]">Cornel 2021</a>). Several economic appraisals of haemoglobinopathies screening in the antenatal and neonatal settings have nevertheless indicated that these strategies are cost‐effective (<a href="./references#CD010849-bbs2-0051" title="DaviesSC , CroninE , GillM , GreengrossP , HickmanM , NormandC . Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technology Assessment2000;4(3):1-99.">Davies 2000</a>; <a href="./references#CD010849-bbs2-0121" title="ZeunerD , AdesAE , KarnonJ . Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technology Assessment1999;3(11):1-186.">Zeuner 1999</a>). A review of existing screening programmes in Australia has shown that targeted preconception screening in certain ethnic groups demonstrates both clinical and cost‐effectiveness (<a href="./references#CD010849-bbs2-0079" title="LewRM , BurnettL , ProosAL , Barlow-StewartK , DelatychiMB , BankierA , et al. Ashkenazi Jewish population screening for Tay–Sachs disease: the international and Australian experience. Journal of Paediatrics and Child Health2014;51(3):271-9.">Lew 2014</a>). </p> <p>At a policy level, preconception genetic risk assessment has been recommended in clinical practice in the Netherlands, the USA and the UK (<a href="./references#CD010849-bbs2-0023" title="American College of Obstetricians and Gynecologists. Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. ACOG Committee Opinion No. 442 Obstetrics &amp; Gynecology2009;114:950-3.">ACOG Committee Opinion 2009</a>; <a href="./references#CD010849-bbs2-0064" title="Health Council of Netherlands. Preconception care: A good beginning. The Hague: Health Council of Netherlands2007. [ISBN: 978-90-5549-678-5]">Health Council of Netherlands 2007</a>; <a href="./references#CD010849-bbs2-0069" title="Human Genetics Commission. Increasing options, informing choice: A report on preconception genetic testing and screening. Human Genetics Commission2011.">Human Genetics Commission 2011</a>). However, a comprehensive review of the current evidence still needs to be undertaken to directly inform healthcare practice. </p> <p>This review will explore if robust trial evidence exists on the effect of preconception genetic risk assessment for genetic disorders, particularly before its widespread routine implementation in current healthcare settings. This is an update of a previously published review (<a href="./references#CD010849-bbs2-0122" title="HusseinN , WengSF , KaiJ , KleijnenJ , QureshiN . Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Cochrane Database of Systematic Reviews2015, Issue 8. Art. No: CD010849. [DOI: 10.1002/14651858.CD010849.pub2]">Hussein 2015</a>; <a href="./references#CD010849-bbs2-0123" title="Hussein  N, Weng  SF, Kai  J, Kleijnen  J, Qureshi  N. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease. Cochrane Database of Systematic Reviews2018, Issue 3. Art. No: CD010849. [DOI: 10.1002/14651858.CD010849.pub3]">Hussein 2018</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010849-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010849-sec-0017"></div> <p>The purpose of this review is to assess the effectiveness of systematic preconception genetic risk assessment to enable autonomous reproductive choice and to improve reproductive outcomes in women and their partners who are identified as carriers of thalassaemia, sickle cell disease, cystic fibrosis or Tay‐Sachs disease in healthcare settings when compared to usual care. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010849-sec-0018" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010849-sec-0018"></div> <section id="CD010849-sec-0019"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010849-sec-0020"> <h4 class="title">Types of studies</h4> <p>We planned for this review to include all relevant randomised controlled trials (RCTs) and quasi‐RCTs. </p> </section> <section id="CD010849-sec-0021"> <h4 class="title">Types of participants</h4> <p>Women and their partners of reproductive age (aged 16 to 50 years old) who are carriers for thalassaemia, sickle cell disease, cystic fibrosis or Tay‐Sachs disease, accessing any healthcare services which include hospitals and community‐based healthcare settings. Community‐based healthcare settings include family or general practices, community health centres, community health services, community or outpatient clinics and ambulatory care services. Settings outside of healthcare do not directly inform healthcare practice, and thus will be excluded as being outside the scope of this review. If trials contain both eligible and ineligible participants, they will be included if data on eligible participants can be extracted. </p> </section> <section id="CD010849-sec-0022"> <h4 class="title">Types of interventions</h4> <p>We planned to assess the effects of systematic preconception genetic risk assessment for thalassaemia, sickle cell disease, cystic fibrosis or Tay‐Sachs disease, in any healthcare setting. We define systematic preconception genetic risk assessment as a package of risk assessment including one or more of these components: </p> <p> <ul id="CD010849-list-0001"> <li> <p>family history assessment;</p> </li> <li> <p>assessment of ethnicity background;</p> </li> <li> <p>genetic carrier testing;</p> </li> <li> <p>genetic carrier screening.</p> </li> </ul> </p> <p>Risk assessment can be offered at anytime prior to conception.</p> <p>We planned to compare systematic preconception genetic risk assessment with standard care. We define standard care as where people receive usual or alternative care in any healthcare setting, that does not involve a specific systematic offer or approach to preconception genetic risk assessment. </p> </section> <section id="CD010849-sec-0023"> <h4 class="title">Types of outcome measures</h4> <p>The listed outcomes do not form part of the eligibility criteria for the included trials. </p> <section id="CD010849-sec-0024"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010849-list-0002"> <li> <p>Reproductive outcomes in women and their partners who are carriers of thalassaemia, sickle cell disease, cystic fibrosis or Tay‐Sachs disease identified during or after pregnancy </p> <ol id="CD010849-list-0003"> <li> <p>number of infants born with genetic conditions</p> </li> <li> <p>number of infants born with congenital anomalies</p> </li> <li> <p>number of infants born with low birth weight</p> </li> <li> <p>number of infants born prematurely</p> </li> </ol> </li> <li> <p>Decisions about future conception and pregnancy in women and their partners who are carriers for thalassaemia, sickle cell disease, cystic fibrosis or Tay‐Sachs disease </p> <ol id="CD010849-list-0004"> <li> <p>number of women or couples who would make use of prenatal diagnosis</p> </li> <li> <p>number of women or couples who would make use of prenatal diagnosis and consider termination of pregnancy if the child is affected </p> </li> <li> <p>number of women or couples who would consider PGT and IVF</p> </li> <li> <p>number of women or couples who would conceive using donated gametes</p> </li> <li> <p>number of women or couples who would consider adoption</p> </li> <li> <p>number of women or couples who would refrain from having any children</p> </li> </ol> </li> <li> <p>Number of women or couples who make an informed choice measured by tools such as the Multidimensional Measure of Informed Choice (MMIC) </p> </li> </ol> </p> </section> <section id="CD010849-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010849-list-0005"> <li> <p>During pregnancy following intervention</p> <ol id="CD010849-list-0006"> <li> <p>gestational date of prenatal diagnosis in at‐risk women</p> </li> <li> <p>gestational date of prenatal counselling in at‐risk women or couples</p> </li> </ol> </li> <li> <p>Self‐reported measures (short‐term change from baseline)</p> <ol id="CD010849-list-0007"> <li> <p>any objective measures of health‐related quality of life resulting from preconception genetic risk assessment, using validated tools such as Short Form Health Survey 36 (SF36) and Health Questionnaire EQ‐5D </p> </li> <li> <p>any objective measures of quantifying psychological or social outcomes or both resulting from preconception genetic risk assessment using validated tools such as Spielberger State‐Trait Anxiety Inventory (STAI), Perceived Stress Questionnaire (PSQ) </p> </li> <li> <p>knowledge (any measures of the women's or couples' or both, knowledge of reproductive genetic risk associated with carrier status for thalassaemia, sickle cell disease, cystic fibrosis or Tay‐Sachs disease using validated self‐reported questionnaire) </p> </li> <li> <p>satisfaction (any measures of the women's or couples' or both, satisfaction with the intervention using validated self‐reported questionnaire) </p> </li> </ol> </li> <li> <p>Cost of the intervention (including follow‐up visits and tests)</p> </li> </ol> </p> </section> </section> </section> <section id="CD010849-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all relevant published and unpublished trials without restrictions on language, year or publication status. If we identify potentially eligible non‐English language trials in future searches, we will source a person who can read the language in order to assess these trials for possible inclusion and data extraction. </p> <section id="CD010849-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We sought trials from the relevant Cystic Fibrosis and Genetic Disorders Group's Trials Registers using the terms: ((carrier* OR trait OR risk assessment OR Tay‐Sachs):kw) AND ((cystic fibrosis OR haemoglobinopathies OR Tay‐Sachs):kw). For full details of all searching activities for the registers, please see the relevant section of the Cystic Fibrosis and Genetic Disorders Group's <a href="https://cfgd.cochrane.org/our-specialised-trials-registers" target="_blank">website</a>. </p> <p>Date of latest search: 04 August 2021.</p> <p>In addition, we searched all relevant trials from the following databases:</p> <p> <ol id="CD010849-list-0008"> <li> <p>Ovid MEDLINE (1970 until 25 June 2021);</p> </li> <li> <p>Ovid Embase ((1974 until 25 June 2021);</p> </li> <li> <p>CINAHL (1970 until 25 June 2021);</p> </li> <li> <p>Ovid PsycINFO (1970 until 25 June 2021).</p> </li> </ol> </p> <p>Date of latest search: 25 June 2021.</p> <p>The search strategies are available in the appendices (<a href="./appendices#CD010849-sec-0073">Appendix 2</a>). Start dates for database searches are set to when carrier screening or testing was first available. Based on WHO reports, earliest carrier status assessment was introduced for Tay‐Sachs disease and haemoglobinopathies from the early 1970s (<a href="./references#CD010849-bbs2-0029" title="AngastiniotisM , ModellB , EnglezosP , BoulyjenkovV . Prevention and control of haemoglobinopathies. Bulletin of the World Health Organization1995;73(3):375-86.">Angastiniotis 1995</a>; <a href="./references#CD010849-bbs2-0073" title="KabackMM . Population-based genetic screening for reproductive counselling: the Tay-Sachs disease model. European Journal of Pediatrics2000;159(3):192-5.">Kaback 2000</a>). We searched for relevant trials in the databases from 1970 or from when the date of the database was first available if after 1970. </p> <p>We searched the following clinical trial databases for ongoing and unpublished trials:</p> <p> <ul id="CD010849-list-0009"> <li> <p><a href="http://clinicaltrials.gov/" target="_blank">National Institutes of Health database</a>; </p> </li> <li> <p><a href="http://apps.who.int/trialsearch/" target="_blank">Clinical Trials Search Portal of the World Health Organization</a>; </p> </li> <li> <p><a href="http:///www.controlled-trials.com/" target="_blank">Current Controlled Trials in the metaRegister of controlled clinical trials</a> </p> </li> </ul> </p> <p>Date of latest search: 25 June 2021.</p> </section> <section id="CD010849-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We planned to examine the reference lists of eligible published trials to identify further relevant trials. We handsearched the key journals <i>European Journal of Human Genetics,</i> <i>Genetics in Medicine</i> and the <i>Journal of Community Genetics</i> from 1998 to June 2021. We complemented the search by contacting subject experts or centres in the field to request any unpublished or other published trials that we may not have identified. </p> </section> </section> <section id="CD010849-sec-0029"> <h3 class="title" id="CD010849-sec-0029">Data collection and analysis</h3> <section id="CD010849-sec-0030"> <h4 class="title">Selection of studies</h4> <p>We saved the results of the searches in the Endnote reference managing software (<a href="./references#CD010849-bbs2-0057" title="EndNote X9. Clarivate, 2009.">EndNote X9</a>). Two review authors (one content expert and one methodologist) independently screened the citations and article abstracts of every retrieved record. We would have resolved any disagreements on eligibility by discussion and if doubt remained, we would have acquired the relevant full article(s) for further inspection. Two review authors independently screened all full‐text articles of the eligible trials. We aimed to resolve any disagreement by discussion. If required, we would have consulted a third review author. If necessary, we planned to contact the authors of the articles for further information and clarification of trials. We have reported reasons for excluding trials and provided a PRISMA flowchart (<a href="#CD010849-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010849-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD010849-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010849.pub4/media/CDSR/CD010849/image_n/nCD010849-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>We did not identify any trials for inclusion in this version of the review. However, if we identify any trials for future updates of the review, we plan to undertake the following. </p> </section> <section id="CD010849-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>Two review authors will independently extract data from each included trial using an agreed data extraction form. We will collect data on trial population characteristics (including sample size, participants' ethnic or cultural characteristics, geographic locations), intervention characteristics (including process and duration of intervention) and primary and secondary outcome measures of interest. We plan to report short‐term outcomes post intervention up to six months. We plan to report long‐term outcomes post intervention from six months up to 12 months, and then annually thereafter. </p> <p>We will settle any disagreements about the data extracted through discussion by the two review authors, and if necessary by arbitration with a third author. We will enter all the data into the Review Manager software (<a href="./references#CD010849-bbs2-0099" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). </p> </section> <section id="CD010849-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We will construct a risk of bias table for each trial as outlined in chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010849-bbs2-0067" title="HigginsJP , AltmanDG , Sterne JA on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (editors). Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook-5-1.cochrane.org/.">Higgins 2011</a>). </p> <p>Two review authors will independently assess and record the following six domains in the risk of bias table: </p> <p> <ol id="CD010849-list-0010"> <li> <p>random sequence generation;</p> </li> <li> <p>allocation sequence concealment;</p> </li> <li> <p>blinding of participants, trial personnel, outcome assessors;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting;</p> </li> <li> <p>other sources of bias.</p> </li> </ol> </p> <p>We will judge the methods used in the trials for each domain as having either a low, high or unclear risk of bias. Two review authors will aim to resolve any disagreements in the judgement of the domains through discussion. If no agreement can be reached, then they will consult a third author and aim to resolve the disagreement by consensus. </p> <p>We will record the information in the 'Risk of bias' tables in Review Manager (<a href="./references#CD010849-bbs2-0099" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). We aim to resolve any disagreement by consensus or arbitration by a third author. We will use the results of the risk of bias assessment to provide an evaluation of the overall risk of bias of the included trials based on the approach outlined in the chapter 8 (Table 8.7a) of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010849-bbs2-0067" title="HigginsJP , AltmanDG , Sterne JA on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (editors). Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook-5-1.cochrane.org/.">Higgins 2011</a>). </p> </section> <section id="CD010849-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>We will extract all the main results of the included trials as mentioned below. We will contact relevant authors of the original reports for data or any missing relevant information or when clarification is needed. We will settle any disagreements about the data extracted through discussion and if necessary by arbitration by a third author. We will enter all the data into the Review Manager software (<a href="./references#CD010849-bbs2-0099" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). </p> <section id="CD010849-sec-0034"> <h5 class="title">Continuous data</h5> <p>For scale‐derived data, we will include continuous data from rating scales only if the measuring instrument has been validated. We will include endpoint data and only use change data if the former are not available. For continuous outcomes we will record mean, standard deviation (SD) and number of participants for each group and report effect size using the mean difference (MD) for the same units of measurement or the standardised mean difference (SMD) when different scales are used to evaluate the same outcome, with 95% confidence intervals (CI). The MD measures the absolute difference between the means in two groups, whereas the SMD is the MD relative to variability observed in that trial. </p> </section> <section id="CD010849-sec-0035"> <h5 class="title">Dichotomous data</h5> <p>We will report dichotomous data using the risk ratio (RR) and the corresponding 95% CIs. </p> </section> </section> <section id="CD010849-sec-0036"> <h4 class="title">Unit of analysis issues</h4> <p>We anticipate cluster‐randomised designs to be used in the included trials; for example, groups of patients of a single doctor or practice. If available, we will extract the direct estimate of the effect (RR with CI) that accounts for a cluster design. We will contact the primary authors of the included trials to obtain the intra‐cluster correlation coefficient (ICC) which will describe the relative variability within and between clusters, to adjust for clustering effect (<a href="./references#CD010849-bbs2-0054" title="DonnerA , KovalJJ . The estimation of intraclass correlation in the analysis of family data. Biometrics1980;36(1):19-25.">Donner 1980</a>). We will meta‐analyse the appropriate analyses of cluster randomised trials using the generic inverse variance method. Alternatively, we will estimate an ICC to describe the relative variability within and between clusters (<a href="./references#CD010849-bbs2-0054" title="DonnerA , KovalJJ . The estimation of intraclass correlation in the analysis of family data. Biometrics1980;36(1):19-25.">Donner 1980</a>). An ICC usually derives from the trial or from other sources (ICC from a similar trial in an existing database) (<a href="./references#CD010849-bbs2-0111" title="UkoumunneOC , GullifordMC , ChinnS , SterneJA , BurneyPG . Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technology Assessment1999;3(5):iii-92.">Ukoumunne 1999</a>). If the ICC is derived from other sources, we will report this and conduct a sensitivity analysis. If the trials were analysed as if the randomisation was performed on the individuals rather than the clusters, we will re‐calculate the correct analysis if we are able to extract the following information: the number of clusters randomised to each intervention group; the mean size of each cluster; and the outcome data ignoring the cluster design for the total number of individuals. </p> <p>If we identify more than one intervention group of interest in a trial, we will analyse the effect of the additional intervention group using pair‐wise comparisons. If the additional intervention group is irrelevant, we will not reproduce the data. </p> </section> <section id="CD010849-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>Whenever possible, we will contact the original investigators and the authors of the included trials to request any missing data. If this is unsuccessful we will deal with missing data as mentioned below. </p> <section id="CD010849-sec-0038"> <h5 class="title">Overall loss of credibility</h5> <p>We will choose that, if for any particular outcome there is a high risk bias for missing data according to the risk of bias assessment, we will not use these data in the analyses and will present the results in the form of a narrative synthesis. </p> </section> <section id="CD010849-sec-0039"> <h5 class="title">Continuous data</h5> <p>If SDs are not reported or available, we will first look for statistics that allow the calculation of the SD (for example, the CI and the standard error (SE) of group means, as well as P values and T values for the differences in means). If this is not possible, we will consider imputing SDs of other included trials. We will examine the consequences of imputations in a sensitivity analysis. </p> </section> </section> <section id="CD010849-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD010849-sec-0041"> <h5 class="title">Clinical heterogeneity</h5> <p>We will consider clinical heterogeneity which can result from differences between trials in characteristics of the populations, interventions and outcomes. We will fully discuss the influence of clinical heterogeneity on the observed effects. </p> </section> <section id="CD010849-sec-0042"> <h5 class="title">Methodological heterogeneity</h5> <p>We will assess for methodological heterogeneity, which can result from differences in characteristics of the trial designs. We will fully discuss the influence of methodological heterogeneity on the observed effects. </p> </section> <section id="CD010849-sec-0043"> <h5 class="title">Statistical heterogeneity</h5> <p>We plan to examine graphs or summary tables of the trials to investigate the possibility of statistical heterogeneity. We plan to consider the I<sup>2</sup> statistic which estimates the proportion of variability in effect estimates that is due to heterogeneity (<a href="./references#CD010849-bbs2-0066" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21(11):1539-58.">Higgins 2002</a>). We will determine the level of heterogeneity by the following reference ranges: low 0% to 40%; moderate 41% to 75%; and high 76% to 100%. We also plan to use the Chi<sup>2</sup> statistic and if the P value is less than 0.10 it will be considered an indication of heterogeneity. If there is a high level of heterogeneity between trials, it may not be appropriate to conduct a meta‐analysis, thus we will present results in a qualitative analysis. These trials will be entered into RevMan and presented on a forest plot with their individual effect sizes, but with no combined effect to give an overall picture of evidence (<a href="./references#CD010849-bbs2-0099" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). </p> </section> </section> <section id="CD010849-sec-0044"> <h4 class="title">Assessment of reporting biases</h4> <p>If we include and combine more than 10 trials, we will create a funnel plot to investigate the possibility of small trial effects (a tendency for the intervention effects estimated in smaller trials to differ from those estimated in larger trials) (<a href="./references#CD010849-bbs2-0106" title="SterneJA , EggerM , Moher D on behalf of the Cochrane Bias Methods Group (editors). Chapter 10: Addressing reporting bias. In; Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook-5-1.cochrane.org/.">Sterne 2011</a>). </p> </section> <section id="CD010849-sec-0045"> <h4 class="title">Data synthesis</h4> <p>We will summarise all trials using narrative synthesis methods. This will involve the use of narrative text and tables to summarise data, consider outcomes in the light of differences in trial designs and address potential sources of bias for each of the trials being reviewed. We will group trials according to types of genetic conditions, and then organise them in terms of intervention and outcomes. We will summarise the results of the trials, including the range and size of any reported associations and important trial characteristics. We will also include a detailed commentary on the major methodological problems or biases affecting the trials, together with a description of how these may have affected the individual trial results. </p> <p>We will use a random‐effects model to conduct the meta‐analysis due to anticipated differences between trial location and population. If there is substantial variation in results, particularly if there is inconsistency in the direction of effect, we will not perform a meta‐analysis. </p> </section> <section id="CD010849-sec-0046"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The authors will perform subgroup analyses where sufficient data are available. In the subgroup analyses, the authors will analyse the data in pre‐specified subgroups of trials that share characteristics of interest, to see whether the intervention effect remains consistent or whether it varies for particular characteristics of trials. For this review, the authors aim to compare the effects of interventions on outcome measures in the following groups by: </p> <p> <ul id="CD010849-list-0011"> <li> <p>healthcare setting (primary, secondary, tertiary care or other);</p> </li> <li> <p>intensity of the intervention (number or duration of intervention sessions);</p> </li> <li> <p>nature of carrier status testing (confirmed genetic carrier status compared to probable carrier status); </p> </li> <li> <p>type of condition.</p> </li> </ul> </p> </section> <section id="CD010849-sec-0047"> <h4 class="title">Sensitivity analysis</h4> <p>If there is a spread of bias across the trials, we will provide two estimates of the intervention effect; firstly for all included trials, and secondly only including trials with an overall assessment of a low risk of bias. </p> </section> <section id="CD010849-sec-0048"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>For future updates of this review, we will present the main results of the included trials in a summary of findings table for each comparison we report. We will group the trials according to types of genetic conditions, interventions (versus usual care) and outcomes. We will include the following outcomes in each summary of findings table. </p> <p> <ul id="CD010849-list-0012"> <li> <p>Number of women or couples who refrain from having biological children with their current partner ‐ up to 24 months post intervention </p> </li> <li> <p>Number of women or couples undergoing IVF with PGT or using donor gametes ‐ up to 24 months post intervention </p> </li> <li> <p>Number of women or couples undergo prenatal diagnosis and consider termination of pregnancy if the child is affected ‐ up to 24 months post intervention </p> </li> <li> <p>Number of women or couples who make an informed choice measured by tools such as the MMIC ‐  at 0 month (at intervention) </p> </li> <li> <p>Psychological outcomes resulting from preconception genetic risk assessment quantified by validated tools such as STAI, PSQ and health perception questionnaires ‐ at three months post intervention </p> </li> <li> <p>Psychological outcomes resulting from preconception genetic risk assessment quantified by validated tools such as STAI, PSQ and health perception questionnaires ‐ at six months post intervention </p> </li> <li> <p>Self‐reported satisfaction score at 0 month (at intervention)</p> </li> </ul> </p> <p>Overall grading of the evidence related to each of the outcome will use the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach. We will grade the certainty of the evidence as high, moderate, low or very low, based on the five GRADE domains: risk of bias, inconsistency, indirectness, imprecision, and publication bias (<a href="./references#CD010849-bbs2-0102" title="SchünemannHJ , HigginsJP , VistGE , GlasziouP , AklEA , SkoetzN , et al. Chapter 14: Completing ‘Summary of findings’ tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventionsversion 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org/handbook.">Schünemann 2021</a>). We will produce the summary of the findings tables using the GRADEpro software. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010849-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010849-sec-0049"></div> <section id="CD010849-sec-0050"> <h3 class="title">Description of studies</h3> <section id="CD010849-sec-0051"> <h4 class="title">Results of the search</h4> <p>Database searching identified 11,531 records. After we screened 6844 unique records,  we retrieved 37 full‐text articles describing 22 unique trials for further analysis. We found no RCTs that were eligible for inclusion in the review. A flow diagram illustrates the search flow process (<a href="#CD010849-fig-0001">Figure 1</a>). </p> </section> <section id="CD010849-sec-0052"> <h4 class="title">Included studies</h4> <p>No RCTs were found to be eligible for inclusion in the review.</p> </section> <section id="CD010849-sec-0053"> <h4 class="title">Excluded studies</h4> <p>We excluded a total of 22 trials. We excluded 12 studies due to their non‐RCT study designs (<a href="./references#CD010849-bbs2-0001" title="AlhamdanNA , AlmazrouYY , AlswaidiFM , ChoudhryAJ . Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genetics in Medicine2007;9(6):372-7. ">Alhamdan 2007</a>; <a href="./references#CD010849-bbs2-0002" title="ArchibaldAD , SmithMJ , BurgessT , ScarffKL , ElliottJ , HuntCE , et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genetic Medicine2018;20(5):513-23. [DOI: 10.1038/gim.2017.134]">Archibald 2017</a>; <a href="./references#CD010849-bbs2-0003" title="BekkerH , ModellM , DennissG , SilverA , MathewC , BobrowM , MarteauT . Uptake of cystic fibrosis testing in primary care: supply push or demand pull?British Medical Journal1993;306(6892):1584-6. ">Bekker 1993</a>; <a href="./references#CD010849-bbs2-0006" title="ChildsB , GordisL , KabackMM , KazazianHH . Tay-Sachs screening: motives for participating and knowledge of genetics and probability. American Journal of Human Genetics1976;28(6):537-49. ChildsB , GordisL , KabackMM , KazazianHH . Tay-Sachs screening: social and psychological impact. American Journal of Human Genetics1976;28(6):550-8. ">Childs 1976</a>; <a href="./references#CD010849-bbs2-0007" title="ClaytonEW , HannigVL , PfotenhauerJP , ParkerRA , CampbellPW , PhillipsJA . Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. American Journal of Human Genetics1996;58(3):617-27. ">Clayton 1996</a>; <a href="./references#CD010849-bbs2-0010" title="HegwerG , FairleyC , CharrowJ , OrmondKE . Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program. Journal of Genetic Counseling2006;15(1):61-70. ">Hegwer 2006</a>; <a href="./references#CD010849-bbs2-0011" title="HennemanL , BramsenI , van der Ploeg, ten Kate, LP. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genetic Testing2002;6(3):195-202. HennemanL , BramsenI , van derPloegHM , AderHJ , van derHorstHE , GilleJJP , et al. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. Journal of Medical Genetics2001;38(10):695-703. HennemanL , BramsenI , vanKempenL , vanAckerMB , PalsG , van derHorstHE , et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics2003;6(1):5-13. LakemanPL , PlassAMC , HennemanL , BezemerPD , CornelMC , ten KateLP . Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine2008;10(11):820-30. ">Henneman 2001</a>; <a href="./references#CD010849-bbs2-0012" title="HonnorM , ZubrickSR , WalpoleI , BowerC , GoldblattJ . Population screening for cystic fibrosis in Western Australia: community response. American Journal of Medical Genetics2000;93(3):198-204. ">Honnor 2000</a>; <a href="./references#CD010849-bbs2-0014" title="PayneY , WilliamsM , CheadleJ , StottNC , RowlandsM , ShickleD , et al. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research Team. Clinical Genetics1997;51(3):153-63. ">Payne 1997</a>; <a href="./references#CD010849-bbs2-0018" title="SalleveltSC , StegmannAP , deKoningB , VelterC , SteylsA , EschM , et al. Diagnostic exome-based preconception carrier testing in consanguineous couples: results from the first 100 couples in clinical practice. Genetic Medicine2021;23:1125–36. ">Sallevalt 2021</a>; <a href="./references#CD010849-bbs2-0019" title="TamborES , BernhardtBA , ChaseGA , FadenRR , GellerG , HofmanKJ , et al. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. American Journal of Human Genetics1994;55:626-37. ">Tambor 1994</a>; <a href="./references#CD010849-bbs2-0021" title="WatsonEK , MayallES , ChappleJ , DalzielM , HarringtonK , WilliamsC , et al. Screening for carriers of cystic fibrosis through primary health care services. British Medical Journal1991;303(6801):504-7. WatsonEK , MayallES , LambJ , ChappleJ , WilliamsonR . Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet1992;340(8813):217-20. ">Watson 1991</a>), while  10 RCTs were excluded because the intervention was not preconception genetic carrier testing or genetic carrier screening for any of the four specified genetic conditions (<a href="./references#CD010849-bbs2-0004" title="CastellaniC , PerobelliS , BianchiV , SeiaM , MelottiP , ZanollaL , et al. An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. American Journal of Medical Genetics2011;155A(4):778-85. ">Castellani 2011</a>; <a href="./references#CD010849-bbs2-0005" title="CallananNP , CheuvrontB , SorensonJR . CF Carrier testing in a high risk population: Anxiety,risk perceptions, and reproductive plans of carrier by &quot;non-carrier'' couples. Genetics in Medicine1999;1(7):323-7. CheuvrontB , SorensonJR , CallananNP , StearnsSC , DeVellisBM . Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives. American Journal of Medical Genetics1998;75(5):461-8. ">Cheuvront 1998</a>; <a href="./references#CD010849-bbs2-0008" title="FanCW , CastonguayL , RummellS , LévesqueS , MitchellJJ , SillonG . Online module for carrier screening in Ashkenazi Jewish individuals compared with in-person genetics education: a randomized controlled trial. Journal of Genetic Counseling2018;27:426-38. [DOI: 10.1007/s10897-017-0133-4]NCT01999257. Efficacy study of an online educational module before carrier genetic screening in persons of Ashkenazi Jewish descent. clinicaltrials.gov/ct2/show/NCT01999257  (first posted 03 December 2013). ">Fan 2018</a>; <a href="./references#CD010849-bbs2-0009" title="FisherL , RowleyPT , LipkinJR . Genetic counselling for beta-thalassemia trait following health screening in a health maintenance organization:comparison of programmed and conventional counselling. American Journal of Human Genetics1981;33(6):987-94. RowleyPT , FisherL , LipkinJR . Screening and genetic counselling for thalassemia trait in a population unselected for interest: effects on knowledge and mood. American Journal of Human Genetics1979;31(6):718-30. RowleyPT , Lipkin M Jr, FisherL . Screening and genetic counselling for beta-thalassemia trait in a population unselected for interest: comparison of three counselling methods. American Journal of Human Genetics1984;36(3):677-89. ">Fisher 1981</a>; <a href="./references#CD010849-bbs2-0013" title="IRCT2015061022651N1. The study of effect of motivational interviewing on adherence to iron supplementation and prenatal diagnostic test in couples suspected to have ß- thalassemia, referring to pemarital counseling center, Zahedan. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061022651N1 (first registered 01 August 2015). [CFGD REGISTER: TH194] MoudiZ , ChermahiniED , Miri MoghaddamE , NavidianA . Motivational interviewing and compliance with carriers screening for beta-thalassemia trait in Zahedan premarital counseling center, Iran. Shiraz e Medical Journal2016;17(10):e41381. [CFGD REGISTER: TH164] [DOI: 10.17795/semj41381]">Moudi 2016</a>; <a href="./references#CD010849-bbs2-0015" title="KauffmanTL , WilfondBS , JarvikGP , LeoMC , LynchFL , Reiss JA et al. Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. Contemporary Clinical Trials2017;53:100-5. [DOI: 10.1016/j.cct.2016.12.007]PunjS , AkkariY , HuangJ , YangF , CreasonA , PakC , et al. Preconception carrier screening by genome sequencing: results from the clinical laboratory. American Journal of Human Genetics2018;102(6):1078-89. ">Punj 2018</a>; <a href="./references#CD010849-bbs2-0016" title="QuigleySJ , LinnaneB , ConnellanS , WardA , RyanP . Psychosocial distress and knowledge deficiencies in parents of children in ireland WHO carry an altered cystic fibrosis gene. Journal of Genetic Counseling2018;27(3):589-96. [CFGD REGISTER: MH75] [DOI: 10.1007/s10897-017-0150-3]">Quigley 2018</a>; <a href="./references#CD010849-bbs2-0017" title="RémusC , StanislasA , BouazzaN , GauthereauV , PolakM , BlancheS , et al. An evaluation of three ways of communicating carrier status results to the parents of children in a neonatal sickle cell screening programme. Frontiers in Pediatrics2020;19(8):300. [CFGDREGISTER: SC420] [DOI: 10.3389/fped.2020.00300]">Rémus 2020</a>; <a href="./references#CD010849-bbs2-0020" title="TemmeR , GruberA , JohnsonM , ReadL , LiuM , LuY , et al. Quality improvement in genetic counseling following false positive newborn screen results for cystic fibrosis: assessment of parental knowledge with the use of an educational video. Pediatric Pulmonology2013;48 Suppl 36:374. [ABSTRACT NO.: 461] [CFGD REGISTER: PC14a] TemmeR , GruberA , JohnsonM , ReadL , LuY , McNamaraJ . Assessment of parental understanding of positive newborn screening results and carrier status for cystic fibrosis with the use of a short educational video. Journal of Genetic Counseling2015;24(3):473-81. [CFGD REGISTER: PC14b] [DOI: 10.1007/s10897-014-9767-7]">Temme 2015</a> <a href="./references#CD010849-bbs2-0022" title="GalloAM , WilkieDJ , WangE , LabotkaRJ , MolokieRE , StahlC , et al. Evaluation of the SCKnowIQ tool and reproductive CHOICES intervention among young adults with sickle cell disease or sickle cell trait. Clinical Nurse Research2014;23(4):421-41. [CFGD REGISTER: SC237d] [DOI: 10.1177/1054773813479377]GalloAM , WilkieDJ , YaoY , MolokieRE , StahlC , HershbergerPE , et al. Reproductive health CHOICES for young adults with sickle cell disease or trait: randomized controlled trial uutcomes over two years. Journal of Genetic Counseling2016;25(2):325-36. [CFGD REGISTER: SC237c] [DOI: 10.1007/s10897-015-9874-0]HershbergerPE , GalloAM , MolokieR , ThompsonAA , SuarezML , YaoY , WilkieDJ ,  . Perception of young adults with sickle cell disease or sickle cell trait about participation in the CHOICES randomized controlled trial. Journal of Advanced Nursing 2016;72(6):1430-40. [CFGD REGISTER: SC237b] WilkieDJ , GalloAM , YaoY , MolokieRE , StahlC , Hershberger PE et al. Reproductive health choices for young adults with sickle cell disease or trait: randomized controlled trial immediate posttest effects. Nursing Research2013;62(5):352-61. [CFGD REGISTER: SC237a] [DOI: 10.1097/NNR.0b013e3182a0316b]">Wilkie 2013</a>). One of these 10 RCTs was previously listed as ongoing (protocol by Kauffman from 2017 identified in earlier search); on assessing the published paper containing the full results, we excluded the trial because the intervention was genome sequencing (<a href="./references#CD010849-bbs2-0015" title="KauffmanTL , WilfondBS , JarvikGP , LeoMC , LynchFL , Reiss JA et al. Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. Contemporary Clinical Trials2017;53:100-5. [DOI: 10.1016/j.cct.2016.12.007]PunjS , AkkariY , HuangJ , YangF , CreasonA , PakC , et al. Preconception carrier screening by genome sequencing: results from the clinical laboratory. American Journal of Human Genetics2018;102(6):1078-89. ">Punj 2018</a>). The tables summarise the study details and reasons for exclusions (<a href="./references#CD010849-sec-0083" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD010849-sec-0054"> <h3 class="title">Risk of bias in included studies</h3> <p>No trials were included in this review.</p> <section id="CD010849-sec-0055"> <h4 class="title">Allocation</h4> <p>No trials were included in this review.</p> </section> <section id="CD010849-sec-0056"> <h4 class="title">Blinding</h4> <p>No trials were included in this review.</p> </section> <section id="CD010849-sec-0057"> <h4 class="title">Incomplete outcome data</h4> <p>No trials were included in this review.</p> </section> <section id="CD010849-sec-0058"> <h4 class="title">Selective reporting</h4> <p>No trials were included in this review.</p> </section> <section id="CD010849-sec-0059"> <h4 class="title">Other potential sources of bias</h4> <p>No trials were included in this review.</p> </section> </section> <section id="CD010849-sec-0060"> <h3 class="title" id="CD010849-sec-0060">Effects of interventions</h3> <p>No trials were eligible for inclusion in this review.</p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010849-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010849-sec-0061"></div> <p>To date, in many countries, reproductive genetic risk assessment for autosomal recessive disorders has focused on the antenatal period and carrier status that has emerged as an incidental finding in neonatal screening. In the antenatal period, carrier status is identified either through formal screening programmes, or opportunistically during antenatal follow up in women at increased risk based on ancestry. During the antenatal period, if both parents are found to be carriers of the genes (at‐risk couples), prenatal diagnostic tests, such amniocentesis, may only be available either late in the first trimester or in the second trimester of pregnancy, which leaves the couple only a short period of time to make limited and difficult choices about termination or continuation of the pregnancy. This limits reproductive choices, with the potential of increased psychological distress in at‐risk couples (<a href="./references#CD010849-bbs2-0088" title="ModellB , MouzourasM , CambaL , WardRHT , FairweatherDVI . Population screening for carriers of recessively inherited disorders. Lancet1980;316(8198):806.">Modell 1980a</a>; <a href="./references#CD010849-bbs2-0089" title="ModellB , WardRHT , FairweatherDVI . Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major. BMJ1980;280(6228):1347-50.">Modell 1980b</a>). The incidental finding of the carrier state during neonatal screening for the specific disorders has highlighted concerns from at‐risk couples about the failure to offer this information prior to pregnancy (<a href="./references#CD010849-bbs2-0081" title="LocockL , KaiJ . Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. British Journal of General Practice2008;58(548):161-8.">Locock 2008</a>). </p> <p>Identifying those couples before pregnancy, who have a confirmed genetic carrier status for thalassaemia, sickle cell disease, cystic fibrosis, or Tay‐Sachs disease may provide the opportunity for individuals or couples to make fully informed reproductive choices such as avoiding pregnancy, pre‐implantation diagnosis, in vitro fertilisation, arranging early prenatal diagnosis, or consideration of adoption. </p> <section id="CD010849-sec-0062"> <h3 class="title" id="CD010849-sec-0062">Summary of main results</h3> <p>There is currently no evidence from RCTs for the impact of genetic risk assessment for these conditions in non‐pregnant women on pregnancy outcomes, informed reproductive choices or psychological adverse effects. </p> <p>We identified a number of observational studies that were excluded from the review (<a href="./references#CD010849-bbs2-0001" title="AlhamdanNA , AlmazrouYY , AlswaidiFM , ChoudhryAJ . Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genetics in Medicine2007;9(6):372-7. ">Alhamdan 2007</a>; <a href="./references#CD010849-bbs2-0002" title="ArchibaldAD , SmithMJ , BurgessT , ScarffKL , ElliottJ , HuntCE , et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genetic Medicine2018;20(5):513-23. [DOI: 10.1038/gim.2017.134]">Archibald 2017</a>; <a href="./references#CD010849-bbs2-0003" title="BekkerH , ModellM , DennissG , SilverA , MathewC , BobrowM , MarteauT . Uptake of cystic fibrosis testing in primary care: supply push or demand pull?British Medical Journal1993;306(6892):1584-6. ">Bekker 1993</a>; <a href="./references#CD010849-bbs2-0006" title="ChildsB , GordisL , KabackMM , KazazianHH . Tay-Sachs screening: motives for participating and knowledge of genetics and probability. American Journal of Human Genetics1976;28(6):537-49. ChildsB , GordisL , KabackMM , KazazianHH . Tay-Sachs screening: social and psychological impact. American Journal of Human Genetics1976;28(6):550-8. ">Childs 1976</a>; <a href="./references#CD010849-bbs2-0007" title="ClaytonEW , HannigVL , PfotenhauerJP , ParkerRA , CampbellPW , PhillipsJA . Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. American Journal of Human Genetics1996;58(3):617-27. ">Clayton 1996</a>; <a href="./references#CD010849-bbs2-0010" title="HegwerG , FairleyC , CharrowJ , OrmondKE . Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program. Journal of Genetic Counseling2006;15(1):61-70. ">Hegwer 2006</a>; <a href="./references#CD010849-bbs2-0011" title="HennemanL , BramsenI , van der Ploeg, ten Kate, LP. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genetic Testing2002;6(3):195-202. HennemanL , BramsenI , van derPloegHM , AderHJ , van derHorstHE , GilleJJP , et al. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. Journal of Medical Genetics2001;38(10):695-703. HennemanL , BramsenI , vanKempenL , vanAckerMB , PalsG , van derHorstHE , et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics2003;6(1):5-13. LakemanPL , PlassAMC , HennemanL , BezemerPD , CornelMC , ten KateLP . Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine2008;10(11):820-30. ">Henneman 2001</a>; <a href="./references#CD010849-bbs2-0012" title="HonnorM , ZubrickSR , WalpoleI , BowerC , GoldblattJ . Population screening for cystic fibrosis in Western Australia: community response. American Journal of Medical Genetics2000;93(3):198-204. ">Honnor 2000</a>; <a href="./references#CD010849-bbs2-0014" title="PayneY , WilliamsM , CheadleJ , StottNC , RowlandsM , ShickleD , et al. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research Team. Clinical Genetics1997;51(3):153-63. ">Payne 1997</a>; <a href="./references#CD010849-bbs2-0018" title="SalleveltSC , StegmannAP , deKoningB , VelterC , SteylsA , EschM , et al. Diagnostic exome-based preconception carrier testing in consanguineous couples: results from the first 100 couples in clinical practice. Genetic Medicine2021;23:1125–36. ">Sallevalt 2021</a>; <a href="./references#CD010849-bbs2-0019" title="TamborES , BernhardtBA , ChaseGA , FadenRR , GellerG , HofmanKJ , et al. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. American Journal of Human Genetics1994;55:626-37. ">Tambor 1994</a>; <a href="./references#CD010849-bbs2-0021" title="WatsonEK , MayallES , ChappleJ , DalzielM , HarringtonK , WilliamsC , et al. Screening for carriers of cystic fibrosis through primary health care services. British Medical Journal1991;303(6801):504-7. WatsonEK , MayallES , LambJ , ChappleJ , WilliamsonR . Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet1992;340(8813):217-20. ">Watson 1991</a>). The majority of these observational studies used before and after intervention designs (<a href="./references#CD010849-bbs2-0003" title="BekkerH , ModellM , DennissG , SilverA , MathewC , BobrowM , MarteauT . Uptake of cystic fibrosis testing in primary care: supply push or demand pull?British Medical Journal1993;306(6892):1584-6. ">Bekker 1993</a>; <a href="./references#CD010849-bbs2-0007" title="ClaytonEW , HannigVL , PfotenhauerJP , ParkerRA , CampbellPW , PhillipsJA . Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. American Journal of Human Genetics1996;58(3):617-27. ">Clayton 1996</a>; <a href="./references#CD010849-bbs2-0010" title="HegwerG , FairleyC , CharrowJ , OrmondKE . Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program. Journal of Genetic Counseling2006;15(1):61-70. ">Hegwer 2006</a>; <a href="./references#CD010849-bbs2-0011" title="HennemanL , BramsenI , van der Ploeg, ten Kate, LP. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genetic Testing2002;6(3):195-202. HennemanL , BramsenI , van derPloegHM , AderHJ , van derHorstHE , GilleJJP , et al. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. Journal of Medical Genetics2001;38(10):695-703. HennemanL , BramsenI , vanKempenL , vanAckerMB , PalsG , van derHorstHE , et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics2003;6(1):5-13. LakemanPL , PlassAMC , HennemanL , BezemerPD , CornelMC , ten KateLP . Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine2008;10(11):820-30. ">Henneman 2001</a>; <a href="./references#CD010849-bbs2-0012" title="HonnorM , ZubrickSR , WalpoleI , BowerC , GoldblattJ . Population screening for cystic fibrosis in Western Australia: community response. American Journal of Medical Genetics2000;93(3):198-204. ">Honnor 2000</a>; <a href="./references#CD010849-bbs2-0014" title="PayneY , WilliamsM , CheadleJ , StottNC , RowlandsM , ShickleD , et al. Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research Team. Clinical Genetics1997;51(3):153-63. ">Payne 1997</a>; <a href="./references#CD010849-bbs2-0019" title="TamborES , BernhardtBA , ChaseGA , FadenRR , GellerG , HofmanKJ , et al. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. American Journal of Human Genetics1994;55:626-37. ">Tambor 1994</a>; <a href="./references#CD010849-bbs2-0021" title="WatsonEK , MayallES , ChappleJ , DalzielM , HarringtonK , WilliamsC , et al. Screening for carriers of cystic fibrosis through primary health care services. British Medical Journal1991;303(6801):504-7. WatsonEK , MayallES , LambJ , ChappleJ , WilliamsonR . Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet1992;340(8813):217-20. ">Watson 1991</a>), while four studies utilised cross‐sectional designs (<a href="./references#CD010849-bbs2-0001" title="AlhamdanNA , AlmazrouYY , AlswaidiFM , ChoudhryAJ . Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genetics in Medicine2007;9(6):372-7. ">Alhamdan 2007</a>; <a href="./references#CD010849-bbs2-0002" title="ArchibaldAD , SmithMJ , BurgessT , ScarffKL , ElliottJ , HuntCE , et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genetic Medicine2018;20(5):513-23. [DOI: 10.1038/gim.2017.134]">Archibald 2017</a>; <a href="./references#CD010849-bbs2-0006" title="ChildsB , GordisL , KabackMM , KazazianHH . Tay-Sachs screening: motives for participating and knowledge of genetics and probability. American Journal of Human Genetics1976;28(6):537-49. ChildsB , GordisL , KabackMM , KazazianHH . Tay-Sachs screening: social and psychological impact. American Journal of Human Genetics1976;28(6):550-8. ">Childs 1976</a>; <a href="./references#CD010849-bbs2-0018" title="SalleveltSC , StegmannAP , deKoningB , VelterC , SteylsA , EschM , et al. Diagnostic exome-based preconception carrier testing in consanguineous couples: results from the first 100 couples in clinical practice. Genetic Medicine2021;23:1125–36. ">Sallevalt 2021</a>). We also identified 10 RCTs; however,  nine of these did not evaluate preconception genetic risk assessment for the four specified genetic conditions (<a href="./references#CD010849-bbs2-0004" title="CastellaniC , PerobelliS , BianchiV , SeiaM , MelottiP , ZanollaL , et al. An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. American Journal of Medical Genetics2011;155A(4):778-85. ">Castellani 2011</a>; <a href="./references#CD010849-bbs2-0005" title="CallananNP , CheuvrontB , SorensonJR . CF Carrier testing in a high risk population: Anxiety,risk perceptions, and reproductive plans of carrier by &quot;non-carrier'' couples. Genetics in Medicine1999;1(7):323-7. CheuvrontB , SorensonJR , CallananNP , StearnsSC , DeVellisBM . Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives. American Journal of Medical Genetics1998;75(5):461-8. ">Cheuvront 1998</a>; <a href="./references#CD010849-bbs2-0008" title="FanCW , CastonguayL , RummellS , LévesqueS , MitchellJJ , SillonG . Online module for carrier screening in Ashkenazi Jewish individuals compared with in-person genetics education: a randomized controlled trial. Journal of Genetic Counseling2018;27:426-38. [DOI: 10.1007/s10897-017-0133-4]NCT01999257. Efficacy study of an online educational module before carrier genetic screening in persons of Ashkenazi Jewish descent. clinicaltrials.gov/ct2/show/NCT01999257  (first posted 03 December 2013). ">Fan 2018</a>; <a href="./references#CD010849-bbs2-0009" title="FisherL , RowleyPT , LipkinJR . Genetic counselling for beta-thalassemia trait following health screening in a health maintenance organization:comparison of programmed and conventional counselling. American Journal of Human Genetics1981;33(6):987-94. RowleyPT , FisherL , LipkinJR . Screening and genetic counselling for thalassemia trait in a population unselected for interest: effects on knowledge and mood. American Journal of Human Genetics1979;31(6):718-30. RowleyPT , Lipkin M Jr, FisherL . Screening and genetic counselling for beta-thalassemia trait in a population unselected for interest: comparison of three counselling methods. American Journal of Human Genetics1984;36(3):677-89. ">Fisher 1981</a>; <a href="./references#CD010849-bbs2-0013" title="IRCT2015061022651N1. The study of effect of motivational interviewing on adherence to iron supplementation and prenatal diagnostic test in couples suspected to have ß- thalassemia, referring to pemarital counseling center, Zahedan. www.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2015061022651N1 (first registered 01 August 2015). [CFGD REGISTER: TH194] MoudiZ , ChermahiniED , Miri MoghaddamE , NavidianA . Motivational interviewing and compliance with carriers screening for beta-thalassemia trait in Zahedan premarital counseling center, Iran. Shiraz e Medical Journal2016;17(10):e41381. [CFGD REGISTER: TH164] [DOI: 10.17795/semj41381]">Moudi 2016</a>; <a href="./references#CD010849-bbs2-0016" title="QuigleySJ , LinnaneB , ConnellanS , WardA , RyanP . Psychosocial distress and knowledge deficiencies in parents of children in ireland WHO carry an altered cystic fibrosis gene. Journal of Genetic Counseling2018;27(3):589-96. [CFGD REGISTER: MH75] [DOI: 10.1007/s10897-017-0150-3]">Quigley 2018</a>; <a href="./references#CD010849-bbs2-0017" title="RémusC , StanislasA , BouazzaN , GauthereauV , PolakM , BlancheS , et al. An evaluation of three ways of communicating carrier status results to the parents of children in a neonatal sickle cell screening programme. Frontiers in Pediatrics2020;19(8):300. [CFGDREGISTER: SC420] [DOI: 10.3389/fped.2020.00300]">Rémus 2020</a>; <a href="./references#CD010849-bbs2-0020" title="TemmeR , GruberA , JohnsonM , ReadL , LiuM , LuY , et al. Quality improvement in genetic counseling following false positive newborn screen results for cystic fibrosis: assessment of parental knowledge with the use of an educational video. Pediatric Pulmonology2013;48 Suppl 36:374. [ABSTRACT NO.: 461] [CFGD REGISTER: PC14a] TemmeR , GruberA , JohnsonM , ReadL , LuY , McNamaraJ . Assessment of parental understanding of positive newborn screening results and carrier status for cystic fibrosis with the use of a short educational video. Journal of Genetic Counseling2015;24(3):473-81. [CFGD REGISTER: PC14b] [DOI: 10.1007/s10897-014-9767-7]">Temme 2015</a>; <a href="./references#CD010849-bbs2-0022" title="GalloAM , WilkieDJ , WangE , LabotkaRJ , MolokieRE , StahlC , et al. Evaluation of the SCKnowIQ tool and reproductive CHOICES intervention among young adults with sickle cell disease or sickle cell trait. Clinical Nurse Research2014;23(4):421-41. [CFGD REGISTER: SC237d] [DOI: 10.1177/1054773813479377]GalloAM , WilkieDJ , YaoY , MolokieRE , StahlC , HershbergerPE , et al. Reproductive health CHOICES for young adults with sickle cell disease or trait: randomized controlled trial uutcomes over two years. Journal of Genetic Counseling2016;25(2):325-36. [CFGD REGISTER: SC237c] [DOI: 10.1007/s10897-015-9874-0]HershbergerPE , GalloAM , MolokieR , ThompsonAA , SuarezML , YaoY , WilkieDJ ,  . Perception of young adults with sickle cell disease or sickle cell trait about participation in the CHOICES randomized controlled trial. Journal of Advanced Nursing 2016;72(6):1430-40. [CFGD REGISTER: SC237b] WilkieDJ , GalloAM , YaoY , MolokieRE , StahlC , Hershberger PE et al. Reproductive health choices for young adults with sickle cell disease or trait: randomized controlled trial immediate posttest effects. Nursing Research2013;62(5):352-61. [CFGD REGISTER: SC237a] [DOI: 10.1097/NNR.0b013e3182a0316b]">Wilkie 2013</a>) and one study involved genome sequencing as the intervention (<a href="./references#CD010849-bbs2-0015" title="KauffmanTL , WilfondBS , JarvikGP , LeoMC , LynchFL , Reiss JA et al. Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. Contemporary Clinical Trials2017;53:100-5. [DOI: 10.1016/j.cct.2016.12.007]PunjS , AkkariY , HuangJ , YangF , CreasonA , PakC , et al. Preconception carrier screening by genome sequencing: results from the clinical laboratory. American Journal of Human Genetics2018;102(6):1078-89. ">Punj 2018</a>). Only a few studies have assessed reproductive intentions (<a href="./references#CD010849-bbs2-0005" title="CallananNP , CheuvrontB , SorensonJR . CF Carrier testing in a high risk population: Anxiety,risk perceptions, and reproductive plans of carrier by &quot;non-carrier'' couples. Genetics in Medicine1999;1(7):323-7. CheuvrontB , SorensonJR , CallananNP , StearnsSC , DeVellisBM . Psychosocial and educational outcomes associated with home- and clinic-based pretest education and cystic fibrosis carrier testing among a population of at-risk relatives. American Journal of Medical Genetics1998;75(5):461-8. ">Cheuvront 1998</a>; <a href="./references#CD010849-bbs2-0011" title="HennemanL , BramsenI , van der Ploeg, ten Kate, LP. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genetic Testing2002;6(3):195-202. HennemanL , BramsenI , van derPloegHM , AderHJ , van derHorstHE , GilleJJP , et al. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. Journal of Medical Genetics2001;38(10):695-703. HennemanL , BramsenI , vanKempenL , vanAckerMB , PalsG , van derHorstHE , et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics2003;6(1):5-13. LakemanPL , PlassAMC , HennemanL , BezemerPD , CornelMC , ten KateLP . Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine2008;10(11):820-30. ">Henneman 2001</a>; <a href="./references#CD010849-bbs2-0021" title="WatsonEK , MayallES , ChappleJ , DalzielM , HarringtonK , WilliamsC , et al. Screening for carriers of cystic fibrosis through primary health care services. British Medical Journal1991;303(6801):504-7. WatsonEK , MayallES , LambJ , ChappleJ , WilliamsonR . Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet1992;340(8813):217-20. ">Watson 1991</a>), whilst no studies have assessed actual reproductive outcomes. Most of the above studies have assessed psychological, attitudes, or knowledge outcomes, but there was some heterogeneity in these outcomes between and within studies. Further, none of the outcome measures for knowledge had used validated instruments. Although study participants recognised the importance of identifying genetic carrier states before pregnancy, different attitudes towards genetic testing were elicited and reproductive intentions varied following positive test results. In the Netherlands, study participants would consider prenatal diagnosis and abortion if an affected foetus is identified (<a href="./references#CD010849-bbs2-0011" title="HennemanL , BramsenI , van der Ploeg, ten Kate, LP. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genetic Testing2002;6(3):195-202. HennemanL , BramsenI , van derPloegHM , AderHJ , van derHorstHE , GilleJJP , et al. Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. Journal of Medical Genetics2001;38(10):695-703. HennemanL , BramsenI , vanKempenL , vanAckerMB , PalsG , van derHorstHE , et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genetics2003;6(1):5-13. LakemanPL , PlassAMC , HennemanL , BezemerPD , CornelMC , ten KateLP . Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genetics in Medicine2008;10(11):820-30. ">Henneman 2001</a>). In contrast, in a study of cystic fibrosis screening conducted in the state of Tennessee in the USA, reproductive intentions were limited by cultural and socio‐political factors, such as insurability, being labelled as 'at risk', a lack of understanding, and religious beliefs about abortion (<a href="./references#CD010849-bbs2-0007" title="ClaytonEW , HannigVL , PfotenhauerJP , ParkerRA , CampbellPW , PhillipsJA . Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. American Journal of Human Genetics1996;58(3):617-27. ">Clayton 1996</a>). In addition, barriers to implementation include legal discrimination (<a href="./references#CD010849-bbs2-0076" title="LaphamEV , KozmaC , WeissJO . Genetic discrimination: perspectives of consumers. Science1996;274(5287):621-4.">Lapham 1996</a>) and religious restrictions on abortion (<a href="./references#CD010849-bbs2-0059" title="FowzanS , Alkuraya, RamziAK . Attitude of Saudi families affected with hemoglobinopathies towards prenatal screening and abortion and the influence of religious ruling (Fatwa). Prenatal Diagnosis2001;21(6):448-51.">Fowzan 2001</a>). Previously there were also concerns about fears of stigma (<a href="./references#CD010849-bbs2-0074" title="KenenRH , SchmidtRM . Stigmatization of carrier status: social implications of heterozygote genetic screening programs. American Journal of Public Health1978;68(11):1116-20.">Kenen 1978</a>). </p> </section> <section id="CD010849-sec-0063"> <h3 class="title" id="CD010849-sec-0063">Overall completeness and applicability of evidence</h3> <p>We did not identify any evidence for inclusion in our review.</p> </section> <section id="CD010849-sec-0064"> <h3 class="title" id="CD010849-sec-0064">Quality of the evidence</h3> <p>We did not identify any evidence for inclusion in our review.</p> </section> <section id="CD010849-sec-0065"> <h3 class="title" id="CD010849-sec-0065">Potential biases in the review process</h3> <p>The review authors have attempted to limit the bias in the review process through multiple authors and non‐author contributors who independently searched for trials, screened titles and abstracts, selected full‐text articles and extracted data. Any disagreements were resolved by group discussion and consensus, and therefore it was unlikely that trials have been incorrectly excluded. Although all clinical trials should be registered, there is always the potential of publication bias. However, attempts have been made to minimise publication bias through searching the grey literature and contacting key experts in the field. </p> <p>In addition, while not of concern for the current review version, for future updates, rather than focusing on single gene‐by‐gene carrier testing for specific autosomal‐recessive conditions as the intervention under study, preconception expanded genetic screening should also be included in searches as this has replaced the single gene intervention in recent years. </p> </section> <section id="CD010849-sec-0066"> <h3 class="title" id="CD010849-sec-0066">Agreements and disagreements with other studies or reviews</h3> <p>This is the only systematic review looking at preconception genetic risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease and there were no randomised controlled trials eligible for inclusion, and therefore no comparisons could be made to other reviews or studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010849-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/media/CDSR/CD010849/urn:x-wiley:14651858:media:CD010849:CD010849-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD010849-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010849.pub4/media/CDSR/CD010849/image_n/nCD010849-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/media/CDSR/CD010849/image_t/tCD010849-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/full#CD010849-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010849.pub4/media/CDSR/CD010849/image_n/nCD010849-FIG-01.png" target="_blank">Open in new tab</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010849.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010849-note-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010849-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010849-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010849-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD010849-note-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD010849-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010849-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010849-note-0004">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010849\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010849\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010849\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010849\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010849\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=VXKc2U6b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010849.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010849.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010849.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010849.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010849.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716357832"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010849.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716357836"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010849.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d9d894d369368',t:'MTc0MDcxNjM1OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 